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Lipids self­assemble into lipid bilayers, which divide bodily tissues into cells
and into functionally specified compartments. Imbalances in the lipid
composition and metabolism take part in severe neurodegenerative diseases
such as Alzheimer’s and Parkinson’s disease. These conditions are currently
only symptomatically treated, and the functional insight into the effects of the
drugs in different stages of the conditions is lacking. In the field of pharmacy,
the current drug design protocols rely on the separate evaluation of the
binding affinity between target protein and drug and the extent of lipid bilayer
permeation, which dictates how likely the drug is to reach its target. For
example, the direct treatment of the central nervous system requires the drug
to cross the blood­brain barrier. Most of the drug target proteins are, however,
permanently attached to the lipid membranes. This thesis hypothesizes that
lipids and proteins can act together in relation to drug action, which chemical
variations in the membrane constituents can profoundly affect.
Oxidative stress induces peroxidation of unsaturated fatty acids,
modulating the membrane properties, such as the permeability to water. It is
of importance to understand how lipid peroxidation influences the extent of
segregation of the domains in the lipid membrane. Although the functionality
of the domains in vivo is elusive, they may be associated with a myriad of
cellular functions, such as the attachment of the actin cytoskeleton. By
measuring lateral diffusion of lipids in Langmuir monolayers, we showed that
the presence of oxidized lipids could irreversibly modulate the miscibility of
the segregated microscale domains. This may affect the action of proteins,
drugs and other molecules that interact with such structures.
Since biological membranes are incredibly complex, consisting of
thousands of molecules, they are challenging to study. Therefore, model lipid
membranes are used in membrane research. In this thesis, these model
systems were characterized using label­free surface­sensitive analytical
techniques. Using the membrane models, we showed that the
membrane­bound catechol­O­methyltransferase (COMT) is able to function at
the membrane­water interface, suggesting that the membrane partitioning
and orientation of its substrates and inhibitors influences the drug efficacy.
Inhibition of membrane­bound COMT is desirable in Parkinson’s disease
since it elevates dopamine levels in the brain. Also, the inhibition prevents the
methylation of levodopa, a dopamine precursor that is currently the primary
therapeutic agent. Therefore, we studied the partitioning of dopamine and
different catechol compounds to model lipid membranes. Partitioning to the
membranes, where the existence of nanoscale domains is proposed, was
limited. The partitioning also seemed to be modulated by the charge,
lipophilicity and hydrogen­bonding capacity of the compounds and surface
charge of the membrane. These factors also affect the orientation of the
compounds in the lipid membrane, which can define the probability of the
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to­be­catalyzed moieties to reach the catalytic site of the protein. To conclude,
the results of this thesis demonstrate that the lipid environment can modulate
drug action, which may have consequences for the design of novel
therapeutics for neuropathological conditions.
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The lipid membranes of the mammalian cells are immensely complex
structures consisting of over a thousand different lipid species (van Meer,
2005). Changes in the lipid composition and metabolism, or alterations in the
chemical structures of lipids, have connections to severe neuropathological
conditions such as Alzheimer’s disease (AD) (Lane & Farlow, 2005; Volinsky
& Kinnunen, 2013), Parkinson’s disease (PD) (Dexter et al., 1989; Fabelo
et al., 2011) and lipidosis­induced dystrophies (Powers et al., 1987). The
inability of cells to repair these impairments implicates disruption in the lipid
homeostasis, which is under delicate regulation by the cellular machinery
(Grimm et al., 2007; Vance & Vance, 2009). The current view is that the
organization of lipids varies across vast spatiotemporal scales, contributing to
the essential cellular functions through protein­protein and lipid­protein
interactions (Jacobson et al., 2007; Kinnunen, 1991; Levental et al., 2020;
Nicolson, 2014; Simons & Ikonen, 1997).
During the past few decades, biophysical and biochemical studies of lipid
membranes have become intertwined with the efforts in medical sciences.
Notably, diseases of the central nervous system (CNS), mostly present in the
aging populations, have driven scientists to look for molecular­level hallmarks
specific for individual pathologies. For example, increasing evidence exists
that α­synuclein aggregation in PD triggers lipid dyshomeostasis affecting
lipid­related neuronal functions such as synaptic vesicle trafficking (Fanning
et al., 2020). Or, as suggested by Fanning et al., is the interplay between
proteins and lipids bidirectional? The question is crucial for the novel
treatment strategies, which have, at the moment, mainly considered PD as a
proteinopathy (Fields et al., 2019).
Attempts in pharmaceutical sciences to study drug action concerning the
physics of the lipid membranes have been limited. For developing new drugs
for the treatment of CNS diseases, there are two main motivations to adopt a
more lipid­centric approach. First, for a drug to be effective, it must permeate
the blood­brain barrier (BBB) in quantities that result in a therapeutic effect
(Pardridge, 2007). Secondly, the drug should reach its desirable target, which
often is a receptor or an enzyme embedded in a lipid bilayer. Besides, the drug
could need to overcome additional lipid barriers, sometimes via facilitated or
active transport by membrane­bound proteins. While both lipophilicity of the
drug, or interactions with the lipids, and affinity to the target protein, have
both been recognized to contribute to its therapeutic effect (Lipinski et al.,
1997; Ma et al., 2014), relationships between the two remain elusive (Peetla
et al., 2011; Seddon et al., 2009; Yin & Flynn, 2016). Therefore, the view that
drug action is merely a manifestation of separate drug­lipid and drug­protein
interactions, i.e. obeying the lock­and­key paradigm of computational drug
design (Conrad, 1992), should be revisited. This different viewpoint has
implications for the evaluation of the drug­target networks, which currently
13
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focus on the identification of all relevant protein targets for individual drugs,
without the focus on the lipid environment of the targets (Cheng et al., 2012;
Yıldırım et al., 2007).
This thesis pursues to elucidate the role of lipids and lipid­embedded
proteins in the modulation of drug action. First, the existing literature is
reviewed, with the focus on what were the crucial subjects and issues that
motivated to conduct the research presented in this thesis. Then, the aims of
the study are formulated and results discussed considering the current
knowledge. Finally, the future endeavors of drug and biomembrane research
are discussed. The advancements in structural biophysics, lipidomics,
biophotonics and in silico methods, should remain as the drivers of the
research during the current decade.
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2 REVIEW OF THE LITERATURE
2.1 BIOLOGICAL MEMBRANES
Biological membranes (Fig. 2.1), or biomembranes, are responsible for
cellular compartmentalization, which allows specific compartments in the
biological environment to perform their essential functions. The fundamental
component of the biological membrane is the lipid bilayer. The lipid
composition of the membranes forming cellular barriers differs drastically
from that of subcellular organelles, for example. Logically, evolution has
adopted lipids to serve this function since they self­assemble to closed
structures due to the minimization of free energy. This review is not in the
scope to discuss every intricacy of biological membranes in detail, such as
membrane fusion, albeit a significant phenomenon and widely studied in
recent years (London, 2015; Petrany &Millay, 2019). The purpose is to give an
illustrative insight into the biological complexity of biomembranes, which
supports the aims of this thesis. Later in this review, membranes are
discussed in the context of how they can be modeled and studied.
2.1.1 LIPIDS
By the general definition, lipid “is a loosely defined term for substances of
biological origin that are soluble in nonpolar solvents” (McNaught &
Wilkinson, 1997). The hydrophobic effect drives the aggregation of lipids in
water, i.e. the water has an entropic tendency to minimize its interfacial area.
Weak interactions, electrostatic in nature, take part in stabilizing the
aggregates. Therefore, lipids can adopt different phase structures based on the
physical geometry of the lipids depicted by their chemical structures. The
biologically most relevant form of the lipid aggregates is the lamellar phase,
which in cells manifests as a single lipid bilayer. In the bilayer, non polar lipid
acyl chains of the two leaflets face each other, and the hydrophilic polar
headgroups are exposed to water.
Lipids provide the structure of the membrane and functional environment
for membrane proteins. Also, they participate in signal transduction, cell
growth and reproduction and trafficking of substances in vesicles (van Meer
et al., 2008). Most lipids include fatty acids, carboxyl acids with an aliphatic
hydrocarbon chain. Triacylglycerols (TAGs), with three acyl chains, are stored
in the fat cells, while most lipids forming cellular membranes are
glycerophospholipids. Diacylglycerol (DAG), with two hydrocarbon chains
attached to glycerol via ester linkages, is connected to phosphate with a
headgroup moiety. In practice, however, the entire structure excluding the
hydrocarbon chains is referred to as the lipid headgroup since the chemical
15
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groups present in the whole moiety dictate its properties such as net charge.
Various nomenclatures related to lipids are presented in Fig. 2.1.
Although the localization of the lipids with different headgroups varies
between tissues and cellular compartments, some general remarks about their
relative abundancies can be made. Phosphatidylcholines (PCs), having a
cylindrical shape, are the primary component of all biomembranes.
Phosphatidylethanolamines (PEs), largely present in the intracellular
membranes, induce negative membrane curvature due to their conical shape,
which drives the formation of nonlamellar structures on their own. Similarly
to PE, anionic phosphatidylserine (PS) is mostly present in the inner leaflet of
the plasma membrane, the primary boundary of the cells (Fadok et al., 1998).
The relative amount of PE and PS in the outer leaflet of the plasma membrane
is kept low by the P4­ATPase enzymes (van Meer et al., 2008). Some minor
lipid species include phosphatidylinositol (PI), phosphatidic acid (PA) and
cardiolipin, which have their specific functions in their prevailing
compartments. Sphingomyelin (SM), with a hydrophobic ceramide backbone,
and cholesterol (Chol), are essential to the structure of the outer plasma
membrane leaflet and have unique properties in contributing to synaptic
Figure 2.1 Simplified depiction of a biological membrane and its components. Adapted with
permission from https://pixabay.com/vectors/biology-cell-diagram-science-41522/ (by Clker­
Free­Vector­Images from Pixabay, accessed 4.6.2020)
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function (Hussain et al., 2019). They may also modulate lateral order in the
plasma membranes (Simons & Ikonen, 1997).
Unsaturation, i.e. the presence of double bonds in the lipid acyl chains, is
the main contributor to increased membrane fluidity and decreased bending
rigidity (Rawicz et al., 2000), due to the double­bond­enabled chain
flexibility. Acyl chain length and the degree of unsaturation are closely related
to the lamellar gel­liquid crystalline (Lβ­Lα) transition temperature (Tm). For a
phase mixing to happen, the entropy of mixing has to overcome the favorable
interactions between the lipid components at a critical set of thermodynamic
variables. These phase boundaries with changing lipid composition are
presented in phase diagrams. The liquid crystalline phase is the most relevant
at physiological temperatures of mammals. Most membrane lipids are
composed of monounsaturated fatty acids (MUFAs) with a single double­bond
in one or both of the acyl chains of the glycerol backbone. Polyunsaturated
fatty acids (PUFAs) are mostly present in the lipid membranes of brain tissues
and are prone to lipid peroxidation (Dexter et al., 1989; Liu et al., 2015). Since
PUFAs cannot be produced endogenously, they are absorbed as nutrients
from the foods consumed in the diet and transported through the blood­brain
barrier via facilitated and passive diffusion mechanisms (Liu et al., 2015).
While unsaturated lipids are in the majority, some lipids in the biomembranes
are saturated, such as sphingomyelins.
2.1.2 MEMBRANE PROTEINS
Integral membrane proteins (IMPs) are permanently residing in the lipid
membrane and therefore integral to the membrane structure (Singer &
Nicolson, 1972). IMPs have multiple classes based on the number of their
transmembrane domains (TMDs) and topology, i.e. the orientation of the
domains (Fig. 2.1). Many IMPs are also glycosylated, containing branched
polysaccharide structures. Traditionally, the complexity of their purification
has hindered the progress in the structural biology of IMPs. Specific
solubilization protocols using detergents and possible reconstitution of the
purified protein to a model membrane system are needed (Seddon et al.,
2004). The presence of co­purified lipids in the x­ray crystal structures of
IMPs implicates that the lipids have a role in maintaining protein integrity via
tight interactions or specific binding sites (Hanson et al., 2008; Marius et al.,
2005; Palsdottir & Hunte, 2004). Incorporation of lipids, such as cholesterol,
in the detergent­solubilized membrane proteins, has shown to be essential to
catalytic IMP activity and successful crystallization (Hunte & Richers, 2008).
The use of lipid cubic phases, where different shapes of lipids are present to
offer a stable environment for the proteins, seems to help with retaining the
IMP activity (de Kruijff, 1997). The relation between protein­ lipid interfacial
tension and the energetics of the rhodopsin signal transduction (Brown, 1994;
Wiedmann et al., 1988) has exemplified the importance of physical membrane
properties in maintaining IMP functionality.
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Human G­protein­coupled receptors (GPCRs) are important signal
transducers sensitive for drugs, hormones and neurotransmitters. For long,
their successful crystallization was impeded by the low relative quantities of
functional receptors during protein expression (Zhao & Wu, 2012). The loss of
electron density in the vicinity of the ligand­binding site of the β2
adrenoreceptor (β2AR) close to the lipid­water interface suggested that lipids
have an ordering effect on the TMDs (Cherezov et al., 2007; Rasmussen et al.,
2007). The impact of lipids on the agonistic action of catecholamines
(Swaminath et al., 2005) is not adequately understood (Jafurulla &
Chattopadhyay, 2012); nevertheless, the fact that membrane­perturbations
affect adrenoreceptor functionality is well known from early biochemical
studies (Cerione et al., 1983; Limbird & Lefkowitz, 1976).
Both rhodopsin and β2AR are polytopic membrane proteins with several
TMDs. Perhaps surprisingly, structural studies of polytopic proteins are more
frequent than monotopic and bitopic proteins having one transmembrane
segment, passing the membrane only partially (monotopic) or fully (bitopic).
The first available crystal structure for a full bitopic protein (CYP51 from
Saccharomyces cerevisiae) suggests that the transmembrane helix may
contribute to the function of the enzyme by orienting the catalytic domain
relative to the lipid bilayer (Monk et al., 2014). Before that, molecular
dynamics simulations were used to investigate the 24­residue
trans­membrane α­helix of the bitopic enzyme membrane­bound
catechol­O­methyltransferase (MB­COMT) together with its 26­residue linker
fragment (Orłowski et al., 2011). This fragment connects the transmembrane
part to the soluble part bearing the catalytic domain. The soluble part is
identical with the soluble COMT isoform (S­COMT). In simulations, an ion
pair formed between the oppositely charged arginine and glutamic acid of the
MB­COMT linker fragment, which indicated a stabilizing effect of the formed
loop structure at the lipid­water interface. MB­COMT has a crucial metabolic
function in the brain, i.e. catalyzing the addition of methyl group to the 3­O
and 4­O (to a lesser extent) hydroxyl groups of catecholamines dopamine and
noradrenaline. Recovery of the enzyme activity during detergent purification
has been modest (Pedro et al., 2015). Interestingly, preference of
catecholamines towards MB­COMT versus S­COMT is roughly 100­fold
higher, but the difference ceases to exist after the introduction of a detergent
Triton­X (Jeffery & Roth, 1984). These factors suggest that the lipid
membrane may contribute significantly on the enzyme functionality.
In addition to the absence of structural and functional insight, topological
features of MB­COMT have been under debate (Chen et al., 2011; Schott et al.,
2010). Considering that calcium, an inhibitor of MB­COMT, is a prevalent
cation in the synaptic cleft (Higley & Sabatini, 2012), intracellular localization
of MB­COMT in the cytosolic side of ER membrane seems plausible
(Myöhänen & Männistö, 2010). Now it is widely agreed that MB­COMT
resides in the rough endoplasmic reticulum (rough ER) (Männistö &
Kaakkola, 1999). This would make MB­COMT a type I IMP with the
N­terminus of the TMD facing the ER lumen, although uniprot.org (The
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Uniprot Consortium, 2020) still lists it as a type II topology based on the study
by Chen et al. (2011). Nevertheless, the studies have not excluded the
possibility of additional isoforms of COMT exhibiting extracellular action
(Schott et al., 2010).
An intriguing quality of the lipid membrane is the reduction of
dimensionality, primarily recognized for peripheral membrane proteins that
operate in both lipid and water environments (Berg et al., 1991). For this
reason, kinetic process rates are influenced by the exchange of the enzyme,
ligands and cofactors between the two­ and three­dimensional spaces (Berg
et al., 2001). These exchange rates may differ drastically from the catalysis
rates, complicating the experiments and the subsequent analysis. For IMPs,
the distinction between enzyme activation in the interface and the water phase
is even more troublesome since the activity of the enzyme cannot be measured
without the membrane (Gelb et al., 2000). Still, interfacial catalysis
performed by an integral membrane protein has been described by Ullrich
et al. (2011) for a lipid­catalyzing enzyme DAG kinase from Escherichia coli.
For IMPs with nonlipid substrates, such action is yet to be construed.
2.1.3 INTERACTIONS IN MEMBRANES
Although covalent bonds between lipids, proteins and carbohydrates are
prominent in membranes, noncovalent interactions described below govern
most of the membrane structure:
• Electrostatic interactions, as such, are often referred to as repulsive or
attractive interactions between anions, cations and chemical groups with a
formal charge.
• Hydrogen bonds, by the name, form between a hydrogen atom and a more
electronegative atom or moiety.
• Steric repulsions exist due to the overlap of electron clouds of the atoms in
the lipid hydrocarbon chains, for example.
• Dipolar interactions are a combination of all interactions where an electrical
dipole formed by partial charges takes part. For example, “van der Waals”
attractions occur between the lipid hydrocarbon chains, contributing to the
chain order.
Hydrophobic effect, although not an interaction per se, contributes to the
insertion of lipidated proteins (Erwin et al., 2016) and secondary structures of
IMPs (Yonkunas & Kurnikova, 2015). Also, a salt bridge is a term used for a
combination of electrostatic interaction and hydrogen bond, typically formed
between the charged amine and carboxyl functional groups. Chemical
moieties of the membrane constituents define the extents of these
interactions, which in turn regulate the physical properties of the membrane
such as lateral pressure (Cantor, 1999; Marsh, 1996) and membrane curvature
(McMahon & Gallop, 2005). In addition to the properties of the lipids
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themselves, variations in the chemical environment of the lipid­water
interface take part in defining the local membrane structure. Interfacial
hydration (Jurkiewicz et al., 2012), local pH gradients (Cherepanov et al.,
2004) and concentrations of osmolytes (Söderlund et al., 2003) are
particularly important.
2.1.4 STRUCTURE OF BIOLOGICAL MEMBRANES
The structural intricacies of biological membranes were long unknown;
nevertheless, the effects of electrolytes on biological membranes were studied
for decades before any currently used techniques existed (Danielli, 1944;
Kedem & Katchalsky, 1958). The famous fluid­mosaic model by Singer &
Nicolson (1972) presented the idea of the membrane as a mosaic where the
lipid bilayer forms the matrix of the biological membrane with sparsely
floating IMPs (Singer & Nicolson, 1972). The model incited increasing interest
in lipid­protein interactions; for example, it was demonstrated that the
physicochemical properties of membranes affect the enzymatic activity of
phospholipase A2 (Verger et al., 1973) and membrane thickness and the
composition of the annular lipid shell regulate the activity of adenosine
triphosphatase (East & Lee, 1982). Notably, while the fluid­mosaic model
argued against a long­range ordering of the integral membrane proteins, it did
not exclude the possibility of short­range order and lateral organization in
general. The thermodynamical reasonings of the fluid­mosaic model are still
relevant, and the model has been since revised by the original authors and
other contributors to account for, e.g. the dynamical nature of membrane
components and nonrandom long­range order maintained by cytoskeletal
systems (Nicolson, 2014).
Lateral organization in biological membranes is perhaps the most
discussed and controversial topic in biomembrane research. Since cells have
different ordered compartments, why should there not be order in the
membranes as well? After the model presented by Singer & Nicolson, distinct
phase  separation in binary lipid mixtures led to consider that such behavior
could also exist in biological membranes (Binder et al., 2003). Indeed, the
plate­model of Jain & White (1977) proposed that the biomembrane would
have “relatively rigid plates or patches that are in relative motion with respect
to each other.” Later, the idea that biomembranes structure their tasks via
functional “rafts” (Simons & Ikonen, 1997) was viewed as a solution to the
problem of how proteins and lipids cooperate in the chaotic environment
driven by thermal fluctuations. In model membranes, lipid­lipid interactions
drive the segregation of sphingomyelin, a high­Tm lipid, and cholesterol, to
liquid­ordered (Lo) phases, or rafts, while unsaturated phospholipids with low
Tm stay in the liquid­disordered (Ld, equal to Lα) phase. The Lo phase is
fundamentally different from the gel (Lβ) phase in terms of less restricted
translational and rotational freedom. Theoretically, the Lo­Ld phase
coexistence depends on the balance between line tension, dipole density
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difference and mixing entropy (Lee et al., 2011). The term “domain” is
traditionally reserved for any lateral assembly in a lipid membrane, while the
raft is a detergent­extracted fraction enriched in sphingomyelin, cholesterol
and proteins attached to glycophosphatidylinositols (GPIs) (Binder et al.,
2003). Therefore, in practice, the term raft is reserved for the proposed
SM­Chol assemblies in biological membranes.
Even though phase­separation prevails in synthetic membranes, the
implications of such action in vivo remain elusive. Foremost, domains studied
in model systems have sizes in micrometers. Possible evidence for rafts in cells
came from a pioneering study by Baumgart et al. (2003), who showed that in
cell­derived GUVs (giant plasma membrane vesicles, GPMVs), under specific
conditions, membrane curvature can drive lateral segregation to distinct Lo­Ld
phases. Later, advances in super­resolution microscopy allowed the detection
of nanoscale Lo­Ld segregation (Eggeling et al., 2009). Conflicting results
came when the specific trapping of sphingomyelin probes was concluded not
to be related to the formation of Lo­Ld domains (Honigmann et al., 2014),
calling the previous findings of “rafts” into question. Thus, the dynamical
coexistence of raft domains has not been captured as initially proposed. The
inherent difficulty of detecting rafts seems to come from the fact that the
existence of domains is highly dynamic. Even single­phase lipids form
short­lived nanoscopic entities arising from a myriad of lipid­lipid and
lipid­protein interactions (Jacobson et al., 2007). The domains could be under
near­critical fluctuations (Veatch et al., 2008), which modulate the lateral
diffusion of the lipids over vast time­scales (Ehrig et al., 2011). Therefore,
while the biological consequences of the raft hypothesis need clarification, the
general scientific consensus is that lateral organization is fundamental to the
membrane architecture (Levental & Levental, 2015; Nicolson, 2014).
An intriguing property of the Lo­Ld boundaries in vitro is their role in
facilitating membrane fusion. The boundaries could serve as interaction sites
for viral peptide­mediated entry (Yang et al., 2015). Another foundational
characteristic of the biological membranes, asymmetry in the lipid bilayer, is
not currently well understood, although its existence has been known for
multiple decades (Rothman et al., 1976). In fact, the dominant presence of PE,
prone to form nonlamellar phases, in the inner leaflet, while the outer leaflet
contains sphingomyelin and cholesterol driving lateral segregation in model
systems, raises the question how can plasma membrane even exist as a bilayer
at all (Ackerman & Feigenson, 2015). A final major conundrum unresolved in
the membrane structure is how cells maintain lipid homeostasis. The
superlattice model (Somerharju et al., 2009), in particular, has proposed an
answer with physical reasoning. Briefly, imbalances in the superlattice, i.e.
the states of free energy minimum the lipid membrane naturally adopts, could
drive the action of the relevant enzymes responsible for maintaining optimal
lipid composition (Hermansson et al., 2011).
Finally, the enormous degree of molecular crowding present in the
biological environment should be acknowledged. While the essence of
biological processes is speculated from relatively simple physicochemical
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foundations, i.e. the building blocks of the system, the complexity of the real
in vivo environment of cells is mostly beyond comprehension. For example,
the estimated range of macromolecule concentrations in cells, 80–400
mg/mL (Homouz et al., 2008), translates into 2­10 millimoles per liter, using
an average protein molecular weight of 40 kDa. Since this range corresponds
to the concentrations of different divalent cations in biological compartments,
macromolecular crowding contributes to the osmotic pressure of the
compartments, and therefore, cellular signaling events and endocytosis
(Miermont et al., 2013; Rauch & Farge, 2000). Similarly, assuming there are
approximately 30,000 proteins per μm2 in a biological membrane (Guigas &
Weiss, 2016), approximately half of the membrane is occupied by proteins. In
this estimate, however, the fraction of protein inside the lipid bilayer and
above the membrane surface is not considered.
2.2 LIPID MEMBRANE MODELS
Because of the complexity of biological membranes, membrane models
(Fig. 2.2) are used to allow a finite amount of physical system parameters,
controlled by the specific design of the experiment. This section reviews the
most widely adopted lipid membrane model systems, which are suited for in
vitro studies of both synthetic membranes and biological membranes isolated
from their native cellular environment. From the model systems not discussed
in detail, lipid nanodiscs are emerging as platforms to study integral
membrane proteins in native­like conditions (Parmar et al., 2018).
Figure 2.2 Representation of the common lipid membrane model systems. Peptides, proteins
and drugs, for example, can be embedded or encapsulated in these systems.
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2.2.1 LANGMUIR MONOLAYERS
While a self­assembled monolayer at an air­water interface does not fully
embody the characteristics of a lipid bilayer, Langmuir monolayers have a
fundamental place in biomembrane research. The areal compression and
expansion of the monolayer allow for the direct investigation of phase changes
in a monomolecular film. The uses of Langmuir monolayers in
biologically­relevant applications are numerous. Lipid­nanoparticle
interactions (Hernandez­Borrell et al., 1990), lung surfactant behavior under
compression (Kulovesi et al., 2010) and interfacial binding of therapeutic or
transmembrane peptides (Posada et al., 2014) have been studied, for example.
A Langmuir­Blodgett trough controls the monolayer area, and it can be
combined with a temperature controller or complementary extensions such as
microscopes and light scattering devices. The basis of the instrument is the
lowering of surface tension of water upon the introduction of surface­ active
species, measured using a plate or a wire subjected to a force proportional to
the surface tension. The surface pressure, Π = γ0 − γ is the difference between
the air­water interfacial tension without (γ0 ≈ 72 mN/m) and with the
monolayer present at the interface. The correspondence between the surface
pressure measured in the Langmuir monolayer experiments and lipid bilayers
has been suggested to occur at the range of high surface pressures (30–35
mN/m), corresponding to the hydrophobic free energy density resulting from
the integration over the interfacial lateral pressure profile (Marsh, 1996).
2.2.2 LIPID VESICLES
Vesicles are closed lipid structures. They are ubiquitous in human tissues,
serving as vehicles for cells to transfer substances intra­ and extracellularly
(Calafat et al., 1993; van der Pol et al., 2012). Unilamellar vesicles consist of
only one lipid bilayer, while multilamellar vesicles (MLVs) can have multiple
bilayers. Further classification is roughly based on the vesicle size: small
unilamellar vesicles (SUVs, <100 nm), large unilamellar vesicles (LUVs,
100–1000 nm) and giant unilamellar vesicles (GUVs, >1000 nm). Vesicles
designed for pharmaceutical drug delivery are often called liposomes (Bunker
et al., 2016), which can function as carriers of therapeutic agents (Maherani
et al., 2013) and gases (Sakai et al., 2009), for example.
SUVs and LUVs are prepared using various methods, most commonly by
sonication, extrusion, or reverse­phase evaporation (Szoka Jr. &
Papahadjopoulos, 1980). The preparation of GUVs requires specific protocols
different from the SUV and LUV preparations. Since the sizes of SUVs and
LUVs are at most few times the diffraction limit of light, GUVs are usually
used in fluorescence imaging and lateral diffusion studies, while SUVs and
LUVs are used in calorimetric and fluorescence spectroscopy studies.
Supported vesicular layers (SVLs) on the solid supports are formed via
non covalent adsorption of the vesicles modulated by the chemical properties
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of the surfaces or as tethered vesicles via covalent linkage of lipids or
intermediate linkers to the surface (Ye et al., 2009).
2.2.3 SUPPORTED LIPID MEMBRANES
Lipid bilayers may be created directly on top of solid supports (e.g. on mica or
SiO2) as freely­floating membranes (Keller & Kasemo, 1998; Salamon et al.,
1996), or as tethered membranes (Atanasov et al., 2005; Giess et al., 2004;
Heyse et al., 1995). Also, monolayers can be formed on hydrophobic supports.
The bilayers on solid supports are called supported lipid bilayers (SLBs) or
supported phospholipid bilayers (SPBs) (Tamm & McConnell, 1985).
Although Langmuir ­Blodgett transfer can be applied to form bilayers,
allowing asymmetric lipid distribution, the most versatile protocol for
freely ­floating SLB formation is perhaps the vesicle rupture approach. While
the details of the process were not known during the early studies, it was
generally accepted that favorable interactions of vesicles with the solid
support lead to accumulation of vesicles on the surface, leading to a critical
vesicle density­ induced vesicle rupture (Keller et al., 2000; Keller & Kasemo,
1998). Anderson et al. (2009) confirmed the role of strong adhesion energy
between vesicles and negatively­charged silicon dioxide (SiO2) in initiating
the vesicle accumulation process in high salt conditions. Chemical properties
of the solid substrate can, therefore, facilitate the SLB formation (Granqvist
et al., 2014; Reimhult et al., 2007), along with the physical properties of the
vesicles and experimental conditions, such as osmotic pressure (Jackman
et al., 2013). A study by Andrecka et al. (2013) using interferometric
scattering microscopy refuted the contribution of vesicle fusion, and instead,
demonstrated the interplay between the energetics of the surface­vesicle
interactions and the subsequent spreading of the nanoscale bilayer patches.
Morphologically stable SLBs, in principle, have an advantage over
supported vesicle systems that they avoid nonspecific surface interactions,
differences in vesicle coverage and contributions from the vesicle
polydispersity and curvature to the interactions. Incorporation of IMPs to the
membranes makes SLBs a versatile platform to study biological interactions
between IMPs and their ligands in a membrane environment (Salamon et al.,
1996). Membranes extracted from cells can be sonicated together with
synthetic vesicles to form vesicles that rupture more easily on solid supports
(Dodd et al., 2009; Lee et al., 2010) to create natural membrane mimic
platforms. Also, peptides can facilitate the formation of the supported bilayer
(Cho et al., 2009; Hardy et al., 2012), although it is unclear to what extent the
peptide influences the membrane properties.
Significant concern about the applications of SLBs has been the possible
hindrances to lipid mobility and protein denaturation due to the proximity of
the solid support. Indeed, diffusion coefficients in SLBs can be approximately
half to those measured in vesicle systems (Pincet et al., 2016; Przybylo et al.,
2006). Incorporation of polymer supports acting as spacers can address these
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concerns by ensuring IMP stability (Pace et al., 2015; Ye et al., 2009). The
preparation process of vesicles does not seem to impact the fluidity of the
SLBs (Lapinski et al., 2007), but is rather controlled by the interactions of the
SLBs with the solid support (Seu et al., 2007).
2.3 EXPERIMENTAL METHODS FOR STUDYING
LIPID MEMBRANES
This section briefly describes the standard experimental methods suited for
the research of model membranes and biological membranes (Fig. 2.3). Many
methods that have provided essential insight into the membrane physics and
architecture are not discussed. For example, electrochemical methods provide
useful information on the electrical properties of the membranes, such as
resistance and capacitance. Important microscopy techniques, not further
discussed, include scanning electron microscopy (SEM), transmission electron
microscopy (TEM) and cryogenic electron microscopy (cryo­ EM). Atomic
force microscopy (AFM) is also not discussed even though it is widely used in
the characterization of supported lipid bilayer morphology in combination
with the surface­sensitive methodologies (Richter & Brisson, 2005).
2.3.1 THERMODYNAMICAL METHODS
Like all structures of matter, lipid membranes obey the laws of
thermodynamics, and thus thermodynamical methods suit well for lipid
membrane studies. Differential scanning calorimetry (DSC) was used in many
pioneering works before more advanced technologies existed and is still the
method­of­choice for the studies on membrane thermal phase behavior. The
thermodynamic parameters of the phase transitions can be derived directly
from the heat capacity measurements. Isothermal titration calorimetry (ITC),
capable of resolving the relevant thermodynamical quantities of binding
processes, has been particularly useful for studying the interaction of drugs
with vesicles (Ikonen et al., 2010; Osanai et al., 2013) and conformational
changes of peptides upon membrane binding (Seelig, 2004); however, there is
uncertainty regarding the effect of vesicle size on the measured enthalpy and
entropy changes (Seelig, 2004).
2.3.2 FLUORESCENCE METHODS
Fluorescence methods have been, and still are, most widely adopted in studies
of both model membrane systems and biomembranes of living cells. Their
applications are numerous and only briefly discussed here. Intrinsic
tryptophan fluorescence is a powerful method to study peptide and protein
insertion to membranes and conformational changes (Christiaens et al.,
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Figure 2.3 Approximate spatiotemporal scales at which different techniques and instruments are
used to study lipid membranes (Chiu & Leake, 2011; Dror et al., 2012; Sezgin et al., 2019). For
SPR & QCM, the length scale represents the sensitivity to changes in the vicinity of the sensor
surface, not the lateral resolution.
2002). Fluorescent labeling of proteins and lipids in GUVs has allowed
determining the partitioning of proteins in Lo­domains (Levental & Levental,
2015). Fluorescent sterols can quantify the kinetics of sterol esterification
(Homan et al., 2012), and the fluorescence resonance energy transfer is a
sensitive approach to detect the nanoscale proximity of probes or intrinsic
residues in membranes in relation to nanoscale segregation (Pathak &
London, 2011), or peptide­lipid interactions (Matos et al., 2010), for example.
Diffusion is a ubiquitous property of matter, suited for characterizing the
degree of lateral or rotational constraints directed to the membrane
constituents. For that purpose, fluorescence correlation spectroscopy (FCS)
allows measuring the fluorescence fluctuations arising from the fluorophore
entering and leaving a focused confocal laser beam. FCS has been combined
with super­resolution microscopy techniques such as stimulated emission
depletion microscopy (STED) (Honigmann et al., 2014). Also, pyrene­labeled
lipids can probe the lateral mobility in the membranes. This has provided
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insight into the lipid peroxidation in the membrane (Borst et al., 2000) and
superlattice membrane ordering (Kinnunen, 1991). Diffusion can also be
measured using fluorescence recovery after photobleaching (FRAP), although
control experiments regarding intrinsic photobleaching of fluorophores and
anomalous diffusion are needed (Pincet et al., 2016). Of single­molecule
microscopy techniques, total internal reflection fluorescence (TIRF)
microscopy has superior capabilities for optical sectioning, and outside of the
traditional imaging applications, it has been used in, e.g. single­molecule drug
binding assays (Gunnarsson et al., 2015) and size calculations for individual
glass­tethered vesicles (Olsson et al., 2015).
While fluorescence methods are powerful tools in biomembrane research
that no label­free methodology can currently match in spatiotemporal
resolution, their use requires careful consideration of the possible
interferences. Generally, the fact that only a minimal relative amount of
fluorophore resides in the membrane does not exclude the possibility that
interactions of the probe with the studied molecules interfere with the studied
phenomena. Fluorophores can partition between different phases depending
on the lipid composition (Chan & Boxer, 2007). Fluorescence quenching of
amino acids present in proteins, generally tryptophans, is often incorrectly
used in ligand binding studies to extract binding stoichiometry on an
assumption of a single quenching mechanism (van de Weert & Stella, 2011).
Also, photophysics of the used fluorophores (Amaro et al., 2016) and possible
false positives in drug assays based on fluorescence (Simeonov & Davis, 2015),
should be acknowledged.
2.3.3 SCATTERING METHODS AND NUCLEAR
MAGNETIC RESONANCE
Small­angle neutron and x­ray scattering are used in studying structural
membrane properties. Since x­rays scatter from electrons and neutrons from
atomic nuclei, they provide slightly different information. X­rays resolve the
distance between electron density maxima of the lipid headgroups, while
neutron scattering provides the total bilayer thickness due to the high
deuterated water­lipid contrast (Kučerka et al., 2015).
Area­per­lipid­molecule, for example, can be then calculated using specific
modeling approaches. Also, volume probabilities are obtained, allowing
comparisons with density calculations from molecular dynamics (MD)
simulations (Pan et al., 2015). Although not belonging to the category of
scattering techniques, nuclear magnetic resonance (NMR), solid­ state NMR in
particular, is sensitive for subnanometer dynamics in the membranes,
allowing the studies of a myriad of membrane ­related properties. These
include ligand binding to membrane proteins (Watts, 2005), enzyme kinetics
in membranes (Ullrich et al., 2011), membrane hydration (Petrache et al.,
2004) and lipid­ion interactions (Roux & Bloom, 2005). Order parameters
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from solid­state NMR are often used to validate the results from MD
simulations (Ferreira et al., 2013).
2.3.4 OPTICAL SURFACE­SENSITIVE METHODS
Optical surface­sensitive techniques are label­free and are able to resolve
changes in the dielectric permittivity of the material due to the exchange of
molecules in the vicinity of the optical sensor surface. In essence, together
with fluorescence techniques, they are biophotonic methodologies. Surface
plasmon resonance (SPR), based on the light­ induced surface plasmon
resonance phenomenon, is sensitive to the interfacial binding events on the
metal sensor surface. It has been an industry­standard in biosensor
applications such as ligand­protein binding studies for screening new drug
candidates (Huber & Mueller, 2006; Lee et al., 2015; Olaru et al., 2015).
Vesicles and lipid bilayers (Abdiche & Myszka, 2004; Heyse et al., 1995; Keller
et al., 2000), also with incorporated membrane proteins (Salamon et al., 1999,
1996) and living cells (Abadian et al., 2014), have been studied extensively
using SPR. While the traditional Biacore (General Electric Healthcare,
Chicago, IL, USA) instruments use the detection of narrow ranges of incidence
angles of p­polarized light, some other devices, such as the multi­parametric
SPR instrument (MP­SPR) from Bionavis (Tampere, Finland), enable to
measure the full range of incidence angles, including the angle of total internal
reflection (TIR). MP­SPR allows for inline correction for changes in bulk
liquid refractive index, without the need for laborious reference
measurements with an empty sensor; however, procedures for performing
and analyzing drug ­lipid interactions exploiting the benefits of the MP­ SPR
instrumentation need further elaboration.
Flow channel­based instruments such as SPR introduce the possibility to
mimic flow conditions in the bloodstream. Also, the flow of liquid over the
sensor surface establishes a constant flow of analyte molecules from and into
the flow channel of the instrument, ensuring that the kinetic equations
governing the interaction do not contain time dependencies for analyte
concentration. This condition fulfills if the assay conditions are not dependent
on the mass transport to the surface, i.e. the liquid flow over the surface
balances the effect of molecular diffusion perpendicular to the surface. Mass
depletion over time is problematic for in vitro enzymatic studies, for example,
since the approximations made in the Michaelis­Menten kinetics may not
hold under these conditions (Rusu, 1998).
Disadvantages of SPR include the somewhat limited throughput, inability
to resolve the mode and location of binding respective to the sensor surface
and insensitivity to anisotropic events such as changes in the orientation of
the membrane­bound species (Lee et al., 2015). Ellipsometry (Howland et al.,
2007), coupled plasmon­waveguide resonance (Salamon & Tollin, 2001),
dual­polarization interferometry (Mashaghi et al., 2008; Swann et al., 2004)
and optical waveguide lightmode spectroscopy (Reimhult et al., 2007) can
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reveal these properties. The orientation of molecules in lipid membranes may
also be studied using infrared spectroscopy, linear dichroism (Lopes &
Castanho, 2005) and vibrational sum frequency spectroscopy techniques
(Tang & Allen, 2009). Although not a light­based method, quartz crystal
microbalance provides complementary information on lipid membrane
models such as changes in viscoelasticity and hydration of the membrane
(Cho et al., 2010). Care is needed, however, when comparing results obtained
using instruments with different means of model membrane formation. The
acquired physical properties of the membranes, e.g. diffusion, thickness and
hydration, are primarily dependent on the type of membrane model,
preparation of the membrane and the used methodology. Instead of seeing a
particular method as superior to another, one should appreciate advantages




This section briefly reviews neurodegeneration in relation to dysfunction in
the lipid homeostasis, which manifests as changes in the membrane lipid
composition and protein functionality. Lastly, the current treatment for
Parkinson’s disease using L­dopa administration and adjunct COMT
inhibitors is discussed. While only Alzheimer’s disease and Parkinson’s
disease are focused on, a multitude of other neurodegenerative diseases are
also associated with disruptions in lipid metabolism (Grimm et al., 2007).
2.4.1 LIPIDS IN NEURODEGENERATIVE DISEASES
The foundational insight from early chromatographic studies showed that the
lipid composition in the brain is linked to disease states (Fillerup & Mead,
1967; O’Brien & Sampson, 1965; Rouser et al., 1965). The dry weight of lipids
of total brain mass varies from around 40 to 70 % in white and gray matter to
approximately 80 % in myelin sheaths (O’Brien & Sampson, 1965).
Procedures for postmortem subcellular fractionation (Swanson et al., 1973)
allowed to study lipid and protein compositions of individual cell types and
cellular fractions (Ayola et al., 1988; Fabelo et al., 2011) and to assess the role
of mineral imbalances present in the pathological conditions (Wenstrup et al.,
1990), for example.
Alzheimer’s disease
Alzheimer’s disease (AD), the most common neurodegenerative disorder, is
characterized by gradually advancing degeneration of neurons (Fig.2.4) in
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Figure 2.4 Representation of a neuronal soma (cell body) and its surroundings. Adapted
with permission from https://pixabay.com/illustrations/drawing-nerve-cell-neurone-732830/
(by Gerd Altmann from Pixabay, accessed 4.6.2020)
various areas of the brain, such as the hippocampus and cerebral cortex. This
leads to cognitive and motor dysfunction, dementia and, eventually, death. A
decrease in total lipid mass was first quantified in the brains of two AD
patients (Rouser et al., 1965). Later, specific loss of PE plasmalogens (Ellison
et al., 1987) and sulfatides (Han et al., 2002) has been demonstrated. The loss
of sulfatides, a class of sphingolipids, is present in myelin, which is crucial for
effective nerve signaling. On the other hand, no decrease in brain
sphingomyelin has been observed, but higher SM in plasma could indicate a
deceleration in the advancement of the disease (Wood, 2012). The decrease in
PE plasmalogens, on the other hand, indicates dysfunction in peroxisomal
lipid metabolism (Wood, 2012). The β­amyloid (Aβ) peptide aggregation to
senile plaques is the prevailing theory for the cause of AD, and the production
of these peptides by the secretase IMPs is regulated by lipids such as
cholesterol, sphingolipids, PIs and PAs (Di Paolo & Kim, 2011; Grimm et al.,
2007). γ­secretase could also be associated with lipid rafts (Di Paolo & Kim,
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2011). Since Aβ is also a regulator of lipid metabolism, Aβ aggregation can
lead to lipid dyshomeostasis due to the disruption in this regulatory cycle (Di
Paolo & Kim, 2011; Grimm et al., 2007). Also, apolipoprotein E isoforms have
been suggested to traffick Aβ and lipids with different efficiencies, which links
dietary considerations to the AD pathologies (Lane & Farlow, 2005). Finally,
negatively­charged lipids such as PS seem to enhance amyloid fibril formation
in model membrane systems (Gorbenko & Kinnunen, 2006).
Parkinson’s disease
In Parkinson’s disease (PD), dopaminergic neurons are lost in the
nigrostriatal pathway. The symptoms of tremors, rigidity and slowness
usually appear after 60 % of the nigral cells have died (Bonifácio et al., 2007).
The disease arises from α­Synuclein (α­Syn) aggregation and misfolding to
Lewy bodies inside presynaptic terminals (Barchet & Amiji, 2009). Therefore,
inhibition of α ­Syn aggregation is the target for novel therapeutic strategies
(Svarcbahs et al., 2016). α­Syn binds to the lipid headgroups of model lipid
membranes via its amphipathic α­helix, leading to a subsequent membrane
remodeling dependent on the presence of curvature­inducing lipids such as
PE (Ouberai et al., 2013). Specifically, binding of α­Syn to the lipid membrane
simultaneously with a chaperone complex regulates presynaptic vesicle
fusion, suggesting the synaptic vesicle exocytosis may be hampered in PD
(Burré et al., 2010). Ineffective cholesterol transport in the brain by
apolipoproteins can also induce excessive interactions of α­Syn with
Chol­containing membranes, highlighting the importance of functioning
cholesterol homeostasis in the brain (Emamzadeh, 2017). These factors can
cooperate with various protein dysfunctions, such as tubulins responsible for
the cytoskeletal function, thus promoting microglia­aggravated
neuroinflammation present even in the early stages of the disease (Chung
et al., 2009). PUFAs have been shown to possibly promote the solubilization
of α­Syn to oligomers (Sharon et al., 2003).
Lipid peroxidation
Reactive oxygen species (ROS) exist naturally as products of oxygen
metabolism, but their amount can increase under stress. Susceptible locations
for lipid peroxidation are mitochondria and pulmonary alveoli, where
unsaturated lipids comprise the lung surfactant (Khabiri et al., 2012). Acyl
chains are prone to degradation at their double­bonds, producing carboxylic
acid and aldehyde derivatives, oxidized phospholipids (oxPLs). Therefore,
PUFAs are highly susceptible to lipid peroxidation, which can modulate
protein­lipid interactions in disease states associated with fibril formation
(Kinnunen et al., 2012). Specifically, lipid peroxidation can induce the
formation of Aβ fibril aggregates and mitochondrial dysfunction in PD due to
the prominent interactions of α­Syn with oxPLs (Auluck et al., 2010;
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Kinnunen et al., 2012; Ruipérez et al., 2010). These findings highlight the
importance of studying oxidative stress­induced changes in the physical state
of lipid membranes.
Biophysical studies on model membrane systems using stable oxPLs have
elucidated the disruptive role of lipid peroxidation in modulating the physical
membrane properties. First, oxPLs induce lateral expansion and membrane
thinning (Mason et al., 1997; Wong­ekkabut et al., 2007) due to the reversal of
the truncated sn­2 acyl chains (Beranova et al., 2010), which also makes them
susceptible for macrophage recognition (Greenberg et al., 2008). As
anesthetics can modulate the miscibility transition temperature of the Lo­Ld
coexistence (Gray et al., 2013), oxPLs can stabilize the domain separation. In
Langmuir monolayers, the acyl chain reversal leads to the increase in line
tension induced by the hydrophobic height­mismatch in the Lo­Ld domain
boundaries (Lee et al., 2011; Volinsky et al., 2012). Also, oxidation products
disrupt membrane asymmetry in SUVs and LUVs by inducing transbilayer
diffusion, i.e. flip­flop, of PS to the outer plasma membrane leaflet (Volinsky
et al., 2011). Lateral diffusion in SLBs has been shown to increase slightly
upon the presence of oxidated lipid species (Beranova et al., 2010). For
cholesterol, intriguing properties have been suggested, such as protection
from free radical attack, oxPL­induced increased water permeability (Mosca
et al., 2011) and structural disorder (Štefl et al., 2014). This draws a parallel to
the function of tocopherols (vitamin E) which have been suggested to interact
with specific proteins, lipids and membrane phases to scavenge free radicals
(Atkinson et al., 2008; Wang & Quinn, 2000), but the insight into this action
has been hindered by the same experimental problems concerning the lipid
raft paradigm. To conclude, while the mechanistic picture of oxPLs acting in
model systems together with various membrane components has become
more detailed, the connection of lipid peroxidation to dynamical nanoscale
events such as phase separation needs further inspection.
2.4.2 PARKINSON’S DISEASE THERAPEUTICS
For noninvasive treatment of CNS diseases, there are two options. Either the
drug or drug carrier crosses the blood­brain barrier and reaches its target
directly, or the drug acts in the periphery. The latter can cause an indirect
effect in the CNS via signaling cascades or treat the adverse symptoms of
another treatment in the CNS or periphery. No new viable treatments for AD
have emerged after 2003 (Hung & Fu, 2017). The current therapeutics mostly
focus on symptomatic treatment using acetylcholinesterase inhibitors and the
inhibition of excess glutamate activity, which would otherwise be neurotoxic
(Hung & Fu, 2017). In PD, COMT is targeted to compensate for the
dopaminergic neuronal loss. The next sections discuss this strategy in detail.
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COMT in dopamine metabolism
Dopamine has two major metabolic pathways in the postsynaptic neurons,
and dysfunction in these routes can lead to excessive neurotransmitter
buildup. Monoamine oxidases (MAO, types A, and B), located in the outer
leaflet of mitochondrial membranes, catalyze the reaction of the amine groups
of the dopamine molecules to aldehydes. Of the two COMT isoforms,
MB­COMT performs 3­O­methylation of dopamine with lower capacity but
has a ten­ to hundred­fold higher affinity for dopamine than S­COMT (Jeffery
& Roth, 1984; Lotta et al., 1995). Thus, it is believed that MB­COMT is the
primary isoform in brain, and S­COMT has a secondary role. COMT activity is
found in all brain areas, especially in microglial cells (Myöhänen & Männistö,
2010), and MB­COMT is found in the postsynaptic neurons of the striatum
(Francis et al., 1987). Both isoforms are coded by the same gene and require
S­adenosyl­L­methionine (AdoMet) and Mg2+ as cofactors, in that order
(Lotta et al., 1995). Val158Met polymorphism of COMT has been linked to an
increased risk of schizophrenia (Egan et al., 2001), involuntary movements
(dyskinesias) during PD treatment (de Lau et al., 2012) and PD­related
cognitive disabilities (Williams­Gray et al., 2008). The mutation has also been
found to diminish the activity (Cotton et al., 2004) and thermostability
(Rutherford et al., 2008) of the enzyme in vitro. Also, 3­methoxytyramine
(3­MT), the 3­O­methylated metabolite of dopamine, has been recognized as a
neuromodulator associated with involuntary movements in mice, elucidating
its role in the dyskinesia developed during L­dopa treatment (Sotnikova et al.,
2010). The main interest in 3­MT has been in its use as a biomarker (Peitzsch
et al., 2013), and not much is known about its biological functions.
COMT as drug target
Unfortunately, only symptomatic treatment of PD is currently possible. It
focuses on elevating the dopamine levels in the striatum, where
administration of L­dopa (levodopa), an endogenous precursor of dopamine,
is the primary treatment. Since no effective therapeutics have emerged for the
last 50 years, L­dopa remains as the “gold standard” (Hornykiewicz, 2010).
L­dopa should cross the BBB via active transport by L­type amino acid
transporters (del Amo et al., 2008), albeit in minimal quantities (Bonifácio
et al., 2007). It is known that BBB starts to restructure during aging (Patel &
Patel, 2017); however, a study using a PD rat model did not conclude notable
changes in the BBB functionality, which would affect the efficacy of L­dopa
treatment in the late stages of the disease (Ravenstijn et al., 2012).
Dyskinesias, resulting from the loss of synaptic plasticity in the corticostriatal
pathway (Picconi et al., 2003), are common in long­term L­dopa treatment.
Since L­dopa is a COMT substrate, it is prone to methylation in the
periphery, reducing its bioavailability and elimination half­life (Ma et al.,
2014). Also, aromatic amino acid decarboxylase (AADC) effectively
metabolizes L­dopa to dopamine in the periphery. Therefore, supplementing
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L­dopa with COMT, AADC and MAO inhibitors in the treatment of PD as
adjuncts is customary. Unfortunately, AADC inhibitors, such as carbidopa,
lead to pulsating dopamine levels, and subsequently, motor impairment
(Müller, 2015). While the first­generation COMT inhibitors were somewhat
toxic, second­generation nitrocatechol compounds developed in the late ’80s
were more promising (Männistö & Kaakkola, 1999). The nitro group in the
catechol ring acts as an electron­withdrawing moiety, inducing a pKa shift and
subsequent deprotonation of the reactive hydroxyl groups (Bonifácio et al.,
2007). As a consequence, nitrocatechols are reversible and competitive
tight­binding inhibitors acting at low nanomolar concentrations (Lotta et al.,
1995), although noncompetitive inhibition has also been suggested (Borges
et al., 1997). Due to their tight­binding nature, nitrocatechols show slow
association and dissociation, which makes the incubation time another
variable in the studies of the enzyme kinetics (Borges et al., 1997).
The main second­generation COMT inhibitors are nitecapone, entacapone
and tolcapone. Their adverse effects include dyskinesia, nausea and dizziness
(Bonifácio et al., 2007). Still, tolcapone was approved in 1997, since it showed
enhanced motor function in PD patients, along with an increase in elimination
half­time and the area under the curve during L­dopa treatment (Olanow &
Watkins, 2007). The methylation to 3­O­methyltolcapone is not a major
metabolic route, and instead, tolcapone is largely excreted to urine via other
routes (Jorga et al., 1999). As a lipophilic compound, tolcapone enters to CNS
and also inhibits striatal COMT, while entacapone acts mainly peripherally
(Nissinen et al., 1992). Entacapone seemed to inhibit rat striatal COMT better
with intrastriatal administration (Forsberg et al., 2005), while nitecapone
does not suppress striatal COMT activity (Männistö & Kaakkola, 1999).
Tolcapone, although still prescribed in some countries, was primarily
withdrawn due to its hepatotoxicity, while entacapone as a liver­safe drug is
still largely in use (Bonifácio et al., 2007; Olanow & Watkins, 2007). The
toxicity of tolcapone has been attributed to patient­specific mitochondrial
dysfunction (Longo et al., 2016). Tolcapone was recently shown to induce cell
apoptosis in vitro and to inhibit the growth of neuroblastoma tumors in a
mouse model, introducing it as a potential treatment for these pathologies
(Maser et al., 2017).
Attributing to the lack of 3D structure for MB­COMT, physicochemical
factors that would enable to develop drugs with the inhibition of MB­COMT in
mind, are not known. Silva et al. (2016) showed promising results for novel
nitrocatechol compounds with prominent BBB permeability and the ability to
differentiate between total rat liver and brain COMT. Robinson et al. (2012)
performed a comprehensive analysis of non­nitrocatechol inhibitors for the
inhibition of human and rat COMT isoforms. A peculiar detail in the
experimental details of the study was the use of a detergent Fos­Choline­12 in
the preparations of the enzymes for in vitro studies. Although it is a lipid­like
detergent, and some success has been found in retaining the MB­COMT
activity using long­chain ionic detergents (Pedro et al., 2018), the effects of the
individual detergents with varying concentrations should be carefully
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investigated. As discussed, if the presence of the lipid membrane is essential
to the catalytic function of MB­COMT isoform, detergent­extraction can result
in a vast underestimation of the inhibitory potential for the compounds
towards the membrane­bound isoform.
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3 AIMS OF THE STUDY
Based on the existing literature, chemical diversity of lipids and alterations in
the lipid membrane composition influence the physical properties of the
membranes and, consequently, cellular functionality. Using model lipid
membranes, the hypothesis of this thesis was to show whether the lipids and
their physicochemical diversity can regulate biointeractions between
membrane proteins, endogenous catechol compounds and pharmaceuticals.
This hypothesis has potential implications for the role of lipid membranes in
modulating drug action, and thus the treatment of (neuro)pathological
conditions where the simple protein­centric paradigm for pharmacological
targeting may not be sufficient. In order to test the hypothesis, the specific
intermediate aims were to:
1. Investigate how the biophysical properties of model membranes are
dependent on the chemical diversity of the lipid species (I, II) and,
specifically, how the chemical modifications (lipid peroxidation) can alter
the lateral organization in model membranes (I).
2. Study how a prominent catecholamine­metabolizing enzyme,
membrane­bound catechol­O­methyltransferase (MB­COMT), functions at
the lipid­water interface (III).
3. Assess the role of the lipid membrane in regulating the MB­COMT
enzyme­substrate activity by investigating the interactions between
catechols and model membranes (III, IV).
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4 MATERIALS AND METHODS
This chapter describes the materials and methods used in the thesis to study
lipid membrane systems. The detailed experimental procedures are specified
in the original publications I­IV. Table 4.1 outlines the used methods and the
physical properties that were studied. Later in the chapter, the term analyte
refers to any chemical entity of interest that is studied using the biophysical
methods. The experiments were performed at 24 ◦C (I) or 20 ◦C (II, III, IV).
Table 4.1 Summary of the experimental methods adopted.
Method Properties studied Publication
Fluorescence correlation Lateral diffusion time (τD), I
spectroscopy (FCS) Miscibility transition pressure (Πm)
Isothermal titration Changes in enthalpy (∆H), entropy (∆S ) III
calorimetry (ITC) and free energy (∆G),
Mole ratio distribution coefficient
(binding constant, K)
Langmuir monolayers Area­per­lipid­molecule (a) I
Surface pressure (Π)
Surface plasmon Area­per­lipid­molecule (a), II, III, IV
resonance (SPR) “Dry” surface­mass density (Γdry),
Membrane distribution coefficient (Dm)
Binding constant (K),
Number of binding sites (n),
Refractive index (nl),
Refractive index increment (dn/dC∗),
Optical thickness (dl)
“Dry” thickness (ddry)
Quartz crystal micro­ Effective thickness (dl) or density (ρl), II, III, IV
balance (QCM) “Wet” surface­mass density (Γwet)
Wide­field microscopy Visualization of lipid domains I
(WFM)
4.1 MATERIALS AND SAMPLE PREPARATION
Table 4.2 shows the lipids used in the experiments of this thesis, along with the
corresponding chemical structures and the publications where the lipids were
used. All lipids were from Avanti Polar Lipids (Alabaster, AL, USA), except
DOPS used in publication IV, which was obtained from Larodan AB (Solna,
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Sweden). In study I, POPC and its oxidated analogs were studied. Lipids with
two monounsaturated oleoyl chains were used in the later studies. While these
lipids are prone to oxidative degradation in air (Khabiri et al., 2012), notable
peroxidation­induced changes inmembrane properties have not been observed
in SUVs (Borst et al., 2000). Lipids were mixed in chloroform (0.15 mg/mL
total lipid) from their respective chloroform stock solutions. The preparation
of SUVs had minor variations between the studies, but the basic principles are
as follows:
1. Chloroform was evaporated using a rotary vacuum system (II, III) or a
nitrogen stream (IV, partly in II) to form a thin film at the bottom of the
glass vial.
2. Thin­film hydration was performed by vigorous shaking of the lipids
dissolved in HEPES­buffered saline (20 mM HEPES, 150 mM NaCl at pH
7.4).
3. Multilamellar vesicles were down­sized using extrusion protocols with a
final extrusion through a 50 nm filter membrane (II, III), or by bath
sonication (IV). After all protocols, the measured mean particle size was
less than 70 nm, measured using dynamic light scattering.
Supported lipid bilayers were formed from the SUVs on SiO2­coated
proprietary SPR sensor chips and QCM crystals using the vesicle rupture
approach, described in more detail in the publications of the thesis.
Table 4.2 Different lipids used in the publications of the thesis.
Abbreviation Full name & chemical structure Publ.







Abbreviation Full name & chemical structure Publ.




DOPS 1,2­dioleoyl­sn­glycero­3­phospho­L­serine II, III, IV
18:1 (Δ9­Cis) PS
DOPE 1,2­dioleoyl­sn­glycero­3­phosphoethanolamine III, IV
18:1 (Δ9­Cis) PE
SM, Sphingomyelin N­(hexadecanoyl)­sphing­4­enine­1­phosphocholine II, IV
(Egg, Chicken)
SM, Sphingomyelin N­(octadecanoyl)­sphing­4­enine­1­phosphocholine I
(Brain, Porcine)





Fluorescence correlation spectroscopy (FCS) measurements were performed
by combining a Langmuir trough (µtrough XS; Kibron, Helsinki) with a
custom inverted confocal microscopy setup based on Olympus IX 71
(Olympus, Hamburg, Germany). The focusing of the microscope in the
direction of the monolayer normal (optical path, z) was established using a
z­scan setup (Humpolíčková et al., 2006). In FCS, the intensity fluctuations
from the excited diffusing fluorophores are analyzed using an autocorrelation
function. This function describes the self­similarity of a signal with a time­lag
τ. The general form of the autocorrelation function for the experiments can be
written by considering the ergodicity property of Brownian motion. In other
words, some fraction T of fluorophores have a lifetime τT in the triplet excited





1 − T + Te−τ/τT
c (1 − T )(4πDTτ)
∫





where c is the mean concentration of particles in the focal area, DT is the
translational diffusion coefficient, and Θ (r) ∼ e−2|r|2/w(z)2 w(0)2/w(z)2 is the
molecule detection function approximated as a Lorentzian­Gaussian function
with an effective beam diameter w(z) in the direction of the optical path. The
autocorrelation function can be simplified knowing that the lateral diffusion
time, i.e. the average time the fluorophore diffuses through the focal area, is
τD = w(z)2/4DT (Humpolíčková et al., 2006):
G(τ, z) = 1 +
(
1 − T + Te−τ/τT
) 1




which can be fitted to the autocorrelation functions obtained from the
experiments at different positions z. The minima for τD and N, the average
number of particles, are calculated considering a parabolic dependence on z.
In study I, a two­component extension of Eq. 4.2 was used to account for
domain migration at the air­water interface. In addition to FCS, a wide­field
microscopy setup was utilized to study the morphology of the segregated
Lo­domains during the miscibility transition process.
4.3 SURFACE PLASMON RESONANCE (SPR)
SPR experiments in this thesis were conducted using dual­wavelength (670
and 785 nm), multi­parametric SPR instruments from BioNavis, Tampere,
Finland (MP­SPR Navi 200 and 200A). Supported lipid bilayers, formed in
situ on sensors coated with SiO2, were used in all publications. Also,
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supported vesicular layers were used in study II. The characterization of the
lipid model membranes in study II was conducted using Fresnel­layer matrix
formalism (in a proprietary software LayerSolver, BioNavis, Tampere,
Finland) utilizing the full reflection spectra as a function of incidence angle, a
characteristic feature of the multi­parametric SPR instrumentation. In
publication III, SPR was only used in the qualitative assessment of the extent
of protein interaction with the model membrane. Study IV relies on Jung
formalism (Jung et al., 1998), where only the changes in the SPR peak
minimum angle and the angle of total internal reflection (TIR) are used in the
analysis. Jung formalism allows to quantify the addition of analyte mass due
to the interactions with the membrane.
4.3.1 FRESNEL­LAYER MATRIX FORMALISM
Fresnel­layer matrix formalism is the basis for the theoretical description of
the reflectance of light from the optical SPR system in a Kretschmann
configuration. A prism (p) is used to couple p­polarized light in a way that
excites surface plasmons at the metal­bulk medium interface at a specific
resonance angle, SPR peak minimum angle (θSPR). The resonance requires
matching of the wave vector components of the incident light and surface
plasmons, parallel to the sensor surface. In the vicinity of the metal boundary,
perturbations in the refractive index induce shifts in the SPR peak minimum
angle due to a change in the resonance condition. The addition of molecules is
modeled by an additional homogeneous film layer between the metal and bulk
medium (b), which can be gaseous or liquid. The Fresnel reflection coefficient


















n2x − n2p sin2 θ, x = p, b ,
where (i, j) are the elements of a matrix M = M1 · . . . · MN . The individual
matrices Mk represent the layer k = 1, . . . ,N between the prism and bulk
medium and depend on the angle of incidence for the laser light (θ), the
wavelength of the light in vacuum (λ0), optical thickness (dk), refractive indices
of the layer (nk) and the prism (np). Since the measured reflectance curve
without the bilayer (l) is first used to find the unknown system­dependent
parameters, only dl and nl, i.e. the physical properties of the bilayer, are left to
solve; however, a continuum of possible solutions for dl and nl exists for one
measurement with specific experimental conditions. In contrast, the use of
two different bulk media in two measurements, preferably air and liquid,
results in two sets of reflectance curves; this allows for the determination of an
exact, analytical, solution (Granqvist et al., 2013). Alternatively, multiple
wavelengths may be used, given that the dispersive characteristics of the
bilayer are known, i.e. the wavelength­ dependence of the refractive index nl(λ)
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(Peterlinz & Georgiadis, 1996; Zhou et al., 2001). In practice, a linear
relationship (constant dn/dλ) between the refractive indices is assumed.
In principle, solving both dl and nl would give useful information about the
structural changes in the membrane, i.e. the net changes in both the optical
membrane thickness and concentration of molecules; however, uncertainties
in the bulk refractive index, nb, introduces additional problems regarding the
determination of the solutions for dl and nl using dual­wavelength analysis. In
study II, this challenge was addressed by varying nb for the other wavelength
until an acceptable range was established for dl and the linear dispersion
coefficient dn/dλ. Due to the sensitivity of the instrument to the changes in nb,
it was not further pursued to resolve both optical thickness and refractive
index after a binding event for an analyte. Therefore, the simpler Jung
formalism was later adopted.
4.3.2 JUNG FORMALISM
The formalism developed by Jung et al. (1998) relates the change in the SPR
peak angle minimum to the wavelength­dependent optical properties of the
adsorbed film (nl, dl) and two system­related parameters, sensitivity
coefficient (S ) and decay length (δ) of the evanescent electric field
perpendicular to the sensor normal:








where R is the response of the SPR instrument in the limit dl ≪ δ, which
approximately holds for a lipid bilayer. From now on, the response is assumed
to have been corrected for the bulk effect, i.e. variations in nb during the
measurement (Fig. 4.1). This is achieved by measuring the sensitivity of the
instrument for the changes in the bulk refractive index using a noninteracting
solute. Since the refractive index of a liquid with dissolved analyte has an
approximately linear dependency on the bulk concentration of the analyte,
Jung model is rewritten as follows:




where (dn/dC∗) is the refractive index increment in reference to the bulk
concentration C∗, and Γdry = cldl denotes the surface­mass density (mass per
unit area) of the bilayer which is the product of the lipid concentration and
optical bilayer thickness. Surface­mass density is referred to as “dry” mass,
since in SPR, the surface­mass density does not vary with different amounts of
coupled water associated with the bilayer.
The refractive index increment can be derived from literature, or
alternatively, measured using the surface plasmon resonance instrument by
calculating the change in the bulk refractive index (∆nb ∼ ∆θTIR) as a function
of the molar analyte concentration (Liang et al., 2010). (dn/dC∗) for lipid
dispersions is not necessarily applicable for a lipid bilayer, thus it does not
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Figure 4.1 A) Reflectance of p­polarized light (|rp(θ)|2) vs. angle of incidence (θ) in the MP­SPR
setup based on the Kretschmann configuration. i) baseline, ii) water injection after SLB formation,
iii) after SLB formation, iv) interaction with an SLB. B) The corresponding SPR response (R = ∆θSPR)
(solid lines) and the change in TIR angle (∆θTIR) vs. time. Asterisk marks the SPR response
corrected for the bulk effect from ∆θTIR.
allow the calculation of surface­ mass density directly from Eq. 4.5. The
(dn/dC∗) for a lipid bilayer is, therefore, not a bulk parameter per se in Eq. 4.5,
but a conversion factor. For the estimation of (dn/dC∗) for hydrated adsorbed
molecules, such as lipids, the nonlinear equation based on the Lorenz­Lorentz








where niso is the isotropic refractive index of the adsorbed film, r is the ratio of
molar refractivity and molecular weight, and ν is the inverse of the density of
the pure film constituent (Cuypers et al., 1983; Reimhult et al., 2004; Salamon
& Tollin, 2001). For lipids, the density of ρl ≈ 1.05 g cm−3 is assumed
throughout this study (Mashaghi et al., 2008). From Γdry, the “dry” thickness
can be estimated as
ddry = νlΓdry. (4.7)
The reason for the use of isotropic refractive indices in calculating dn/dC∗
lies in the birefringence of lipid bilayers. Surface plasmon resonance
instrumentation relying only on a plasmon excitation with p­polarized
incident light does not resolve both ordinary and extraordinary refractive
index components. For lipid bilayers exhibiting uniaxial birefringence, the
measured values of nl are closer to the refractive index of the extraordinary
wave, which is approximately parallel to the lipid chains and the membrane
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normal (Salamon et al., 1999). A coupled waveguide spectroscopy extension
can provide the perpendicular component of the refractive index, or the
isotropic refractive index could be estimated from the measurements
(Mashaghi et al., 2008; Salamon & Tollin, 2001).
After the conversion of the measured response to surface­mass density,
kinetics and partitioning of the analytes interacting with the supported lipid
membrane can be described. The logarithm of the partition coefficient (log P,
for undissociated analyte species) and distribution coefficient (log D, for all
species at specific pH) are important descriptors in the pharmaceutical drug
design process in predicting the extent of passive diffusion through
membranes. Assuming that the binding follows kinetics where one analyte
molecule binds to one binding site on the membrane (Figueira et al., 2017),





where Γmaxa is the maximal surface­mass density capacity for the analyte
binding to the membrane, K is the mole ratio distribution coefficient or the
binding constant, and Ma is the molecular weight of the analyte. Maximal







where γ ≈ 0.5 for a bilayer (Jodko­Piorecka & Litwinienko, 2013). The binding
constant, K, is equivalent to the inverse of the dissociation constant,
Kd = kd/ka, widely used in binding studies of ligands interacting with
surface­deposited biomolecules. In the linear range of analyte concentrations,









which is measured using the linear change in adsorbed surface­mass density
(Γa) as a function of analyte concentration in bulk (C f ).
4.4 QUARTZ CRYSTAL MICROBALANCE (QCM)
Quartz crystal microbalance (QCM) utilizes piezoelectric properties of a quartz
crystal. In the impedance­based QCM instrument (KSV Instruments Ltd,
Helsinki, Finland) used, electric impedance is measured as a result of an
alternating voltage coupled to a standing acoustical shear­wave above the
sensor surface. Equivalent circuit analysis further relates the mechanical
surface perturbations to the components of the complex impedance. Using
classical Kelvin­Voigt, or viscoelastic modeling, the shift in the complex
resonance frequency at different frequency harmonics (N = 1,3,5,. . . ) in
reference to the background shift from liquid (b0) is modeled as follows
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(Nalam et al., 2013; Rodahl & Kasemo, 1996; Voinova et al., 1998):
(4.11)





















where ω̃N = 2πi f0N is defined as the 2πi­multiples of the fundamental
frequency f0 (4.95 MHz in the impedance­based QCM instrument used; ρq =
density and µq = shear modulus of the quartz). The viscoelastic nature of the
adsorbed film with density ρl and effective thickness dl is described by the
energy dissipation, ∆D, which depends on the viscosity (ηl) and elastic
modulus (Kl) of the layer. The bulk effect due to high analyte concentrations is
accounted for by deriving the variation in the product ρbηb from the
measurements with an empty quartz crystal. In the limits (ηl,Kl)→ ∞, Eq.4.11
reduces to the linear Sauerbrey equation characterizing a rigid film. Eq. 4.11
was fully used in IV, while the Sauerbrey equation was used in II. In the SLB
formation process, the film layer is initially viscoelastic as the vesicles are
adsorbing on the surface, but the SLB, while formed, becomes rigidly coupled
with the quartz crystal, seen as vanishing energy dissipation (Keller et al.,
2000). Since Eq. 4.11 governs only the product of the effective film thickness
and density, the model does not resolve both. The fitting of the data to the
equations with different harmonics results in the surface­ mass density
Γwet = dlρl, (4.12)
where the surface­mass includes the coupled water, and usually ρl is taken
from the literature, which leaves the dl to be a variable. When used in parallel
with the SPR instrument, this allows estimating the degree of hydration of the
lipid bilayer through equation Γwater = Γwet − Γdry (Reimhult et al., 2004, 2006);
however, synchronization of the flow in the two instruments is desirable to
ensure similar conditions for the SLB formation (Viitala et al., 2012).
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5 RESULTS AND DISCUSSION
In this chapter, the main results of the thesis are discussed. First, the effects
that chemical modifications and lipid diversity may induce on physical
membrane properties are described. Then parallels are drawn between the
methodologies developed in the thesis and screening of drug­lipid interactions
with experimental and computer­assisted workflows. The chapter concludes
with an insight into the interplay between lipids and integral membrane
protein catalysis relevant to the catecholamine metabolism and drug action.
5.1 SURFACE­SENSITIVE METHODOLOGIES
REVEAL CHANGES IN THE PHYSICAL
MEMBRANE PROPERTIES UPON
CHEMICAL MODIFICATIONS
5.1.1 LATERAL ORGANIZATION OF THE MEMBRANE IS
STABILIZED BY OXIDIZED LIPIDS
Diffusion times in POPC and POPC­PazePC monolayers are linearly
proportional to the surface pressure (Fig. 5.1A), highlighting the finding that
they mix ideally as a single Ld phase (Grauby­Heywang et al., 2016). While 25
% PazePC induces expansion in the critical area­per­lipid from 0.46 nm2 to
0.50 nm2, no differences in the diffusion times are seen between POPC and
POPC­PazePC monolayers. On the contrary, in ternary raft mixtures
(POPC­oxPL­SM­Chol), the disintegration of the distinct Lo domains,
miscibility transition, is highlighted by an abrupt increase in the diffusion
times of the Ld­partitioning fluorophore (Fig. 5.1B). Quantitatively, this is
marked as a position of the maximal slope of the τD(Π) curve, giving
miscibility transition pressures of 11.7 mN/m (POPC­SM­Chol), 18.7 mN/m
(25 % of POPC substituted by PazePC) and 20.4 mN/m (25 % of POPC
substituted by PoxnoPC). Interestingly, the compression­expansion cycle
performed for domain­forming mixtures with POPC and POPC­PazePC in the
Ld­phase showed complete reversibility of the Lo­domain structures when the
surface pressure was reduced back to the starting point (Fig. 5.1C). For
POPC­PoxnoPC, by contrast, the expansion was first seen as a formation of
striped structures and then as morphologically heterogeneous domains not
corresponding to the initial structures. While the surface potential was not
measured, this leads to the conclusion that the expansion of the monolayer
induces a shift in the balance between line tension and dipolar interactions,
where the latter drives the formation of the striped domains (Volinsky et al.,
2012).
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Figure 5.1 Diffusion time (τD) vs. surface pressure (Π) for A) POPC monolayers with 0 % or 25
% of POPC substituted by PazePC, B) POPC­SM­Chol (1.5:1.5:1) with 0 %, 12.5 %, or 25 % of
the POPC fraction substituted by PazePC/PoxnoPC. C) Wide­field imaging of the POPC­SM­Chol
mixtures with 0 or 25 % of the POPC fraction substituted by PazePC / PoxnoPC. Adapted from I
(Figs. 2, 3, 5), with permission from Elsevier (see details on page ??).
A previous study using Langmuir monolayers and Brewster angle
microscopy highlighted that the prevalent mechanism in the domain
stabilization by oxPLs is the modulation of line tension at the Lo­Ld phase
boundaries (Volinsky et al., 2012). While the possibility that the domains
merely shrink from microscale to nanoscale entities cannot be fully excluded,
the sigmoidal shape of the diffusion time as a function of surface pressure
suggests that the miscibility transition is genuinely a phase transition. The
resemblance to the thermal phase behavior of diffusion coefficients measured
for cushioned SLBs is evident (Sterling et al., 2013); however, four­component
model membranes have demonstrated the possibility that the transition would
be a manifestation of line tension modulating the domain size to a dimension
not visible by optical means (Ackerman & Feigenson, 2015). WFM imaging
further supports the view that the domains do not merge or change size during
the transition as suggested (Volinsky et al., 2012), but rather the
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height­mismatch­induced line tension keeping the circular domains intact is
abruptly lost at critical surface pressure, resembling a transition to a single
phase. The average sizes of the domains for oxPL­containing compositions
were the same as for POPC­SM­Chol (I, Fig. 4). Therefore, the results do not
support the notion that the line tension and dipole density would be able to
modulate the domain size continuously (Lee et al., 2011). Nevertheless,
nanoscale domains could still exist in the monolayer as dynamical entities that
form and disintegrate at very fast time scales. In bilayers, these domains can
be interleaflet­coupled (Vinklárek et al., 2019) and function as protein­sorting
platforms (Stone et al., 2017), which can be seen as very heterogeneous
diffusional behavior (Yamamoto et al., 2017). Indeed, the existence of
nanodomains with roughly estimated sizes of 4–15 nm has been demonstrated
in vesicles with similar composition than studied here (Pathak & London,
2011).
Regardless of the underlying mechanism of nanodomain regulation, the
results suggest that oxPLs can modulate the Lo­Ld phase behavior by shifting
the critical transition point. This has importance if the biomembrane exists
under near­critical conditions (Cebecauer et al., 2018) with sensitivity to
physical changes such as changes in the lateral pressure profile. The
differences between PazePC and PoxnoPC can be attributed to the different
acyl chain orientations (Beranova et al., 2010; Khandelia & Mouritsen, 2009).
The aldehyde moiety in PoxnoPC, inducing chain orientation parallel to the
membrane surface, may stabilize the domains via interactions with Lo
components, while the more upwards oriented carboxyl moiety in PazePC
interacts preferably with the interfacial cations. The partial chain reversal of
PoxnoPC can also protect it from the recognition by macrophage scavenger
receptors (Beranova et al., 2010; Greenberg et al., 2008). Local membrane
thinning can further contribute to the height mismatch at the domain
boundaries (Parra­Ortiz et al., 2019), and cholesterol stabilizes the
peroxidation­induced perturbations (Štefl et al., 2014).
Although the miscibility transition here is governed by high cooperativity
of only a few different lipid components, the enormous amount of different
membrane constituents should contribute to the broadening of these
transition events in biological membranes, analogous to the temperature
phase transitions (Wallgren et al., 2012). As an opposing argument to domain
stabilization, Brameshuber et al. (2016) demonstrated that the effect of oxPLs
in live cell membranes may be indirectly destructive rather than stabilizing,
thus affecting the nanoscale domain disintegration via modulation of
sphingomyelinase activity. No physical consequences were associated with
domain stability. This discrepancy with the model membrane studies is
expected, given the complexity of biological membranes. Then, the
fundamental limitations of the used methodologies should be acknowledged
when considering the biological relevance of the results. Foremost, the
experiments were performed with i) monolayers formed on an air­water
interface, ii) domains with the micrometer size range and iii) ranges of
miscibility transition pressures that do not correspond to the
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currently­assumed equivalence pressures for monolayer­bilayer comparisons,
i.e. 30–35 mN/m (Marsh, 1996). While the diffusion coefficients were not
calculated due to the uncertainties of the monolayer axial positioning during
the experiments, some estimations of the order of magnitude can be made
assuming a reasonable beam waist diameter of 250 nm. Diffusion times of
∼0.8 and ∼1.5 ms at 32 mN/m for the nondomain and domain­forming
monolayers would translate into 20 and 10 μm2/s, respectively. The range of
2–5 μm2/s has been measured for SLBs (Humpolíčková et al., 2006; Pincet
et al., 2016; Przybylo et al., 2006; Sterling et al., 2013) and 4–8 μm2/s for
free­standing bilayers (Pincet et al., 2016; Przybylo et al., 2006); however,
quantitative comparisons between different studies are not straightforward,
since the lateral diffusion is largely influenced by the used model system and
properties of the chosen fluorophores. In live cells, diffusion coefficients are
notably lower (Schneider et al., 2017), probably due to the extensive molecular
crowding (Guigas & Weiss, 2016). For example, bi­modal distribution of
diffusion coefficients with effective values of 0.04 and 0.3 μm2/s was observed
in live neurons imaged by super­resolution microscopy (MacGillavry &
Blanpied, 2013).
5.1.2 BIOPHYSICAL CHARACTERISTICS OF
SUPPORTED LIPID BILAYERS
Morphologies of the vesicle­based model membrane systems depend on many
factors, such as vesicle polydispersity and deformation under flow. Since SLBs
are formed from these dispersive vesicle solutions, the aim of study II was to
investigate the quality of the SLBs by evaluating their biophysical properties
and to find instrument­specific parameters to differentiate between vesicle and
bilayer arrangements on the sensor surface.
The refractive indices of 1.477–1.486 (Fig. 5.2B) obtained for the SLBs
agree with both theoretical calculations (Huang & Levitt, 1977) and
dual­polarization interferometry measurements where the bilayer was probed
with two perpendicular polarization modes (Mashaghi et al., 2008). Although
membrane “thickness” (Fig. 5.2A) is always a method­dependent structural
quantity, it is of interest to compare the obtained structural data for SLBs with
the information gained using the standard methodologies for membrane
biophysics, namely x­ray and neutron scattering. The most distinct difference
is seen between DOPC and POPC, where the unsaturation in the sn­1 chain
increases the area­per­molecule (Fig. 5.2B) for DOPC from 0.62 to 0.65 nm2.
POPC had a higher average thickness (3.90 nm) than DOPC (3.81 nm).
Kučerka et al. have measured values of 3.91 nm, 0.643 nm2 for POPC
(Kučerka et al., 2011), and 3.89 nm, 0.669 nm2 at 30 ◦C (Kučerka et al., 2009).
According to the results in study II, DOPS might induce lateral compression
in the bilayer, as proposed previously (Petrache et al., 2004); however,
differences are comparable to errors calculated from the three separate SLB
depositions. The observed increase in hydration in DOPC­DOPS bilayers
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Figure 5.2 A) Modeled optical thickness and “dry” thickness for the SLBs. B) Refractive indices
at 670 nm and 785 wavelengths obtained using inverse dual­wavelength modeling. C) Area­per­
lipid­molecule of the SLBs. D) The number of water molecules per lipid associated with the SLBs.
Molar ratios for lipid mixtures were 7:3 (DOPC­DOPS) and 1:1:1 (DOPC­SM­Chol). Adapted from
II (Tables 1, 2) with permission from the American Chemical Society (see details on page ??).
when compared to DOPC can arise from the electrostatic repulsions between
the PS headgroups and the negatively­charged SiO2 surface, or the increased
hydration of the headgroups themselves. Approximately 13 water molecules
per lipid were obtained for POPC using a similar parallel SPR­QCM approach
(Reimhult et al., 2004); however, errors in the hydration calculations in study
II were rather high due to the use of both SPR and QCM data in the analysis.
Membrane thickness of 4.56 nm and area­per­lipid­molecule of 0.42 nm2
are close to the values for equimolar raft mixtures studied in atom­scale MD
simulations (4.40 nm and 0.41 nm2), where the latter is attributed to the
strong condensing effect by cholesterol (Niemelä et al., 2007). The height
difference between Lo and Ld domains can be roughly estimated as a thickness
difference between DOPC and DOPC­SM­Chol, i.e. 0.7 nm, agreeing with the
value of 0.6 nm found using AFM (Rinia et al., 2001). In conclusion,
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biophysical characteristics of the formed DOPC­SM­Chol membranes support
their suitability for further studies with membrane­binding ligands.
In addition to SLBs, SVLs composed of gel­phase DPPC vesicles were
immobilized via nonspecific adsorption to the SiO2 surface. Refractive indices
for the SVLs, 1.36–1.38, agree with other studies for synthetic vesicle
dispersions (Chong & Colbow, 1976) and EVs (Rupert et al., 2018). Layer
thicknesses depended on the used procedure for analysis, but the possible
values of 37 or 76 nm reflect the effect of partial vesicle coverage (estimated as
71 % in II, Table 3) in homogeneous Fresnel­layer modeling.
Optical modeling of the vesicle rupturing event (II, Fig. 3A) shows the
possibility that, although the effective thickness of the surface­bound layer is
increasing due to the vesicle adsorption, the change in refractive index is
limited. Thus, the SPR response increases linearly in time; however, the SPR
response results from the changes in both variables, and therefore, this
homogeneous layer approach does not capture the exact morphological
restructuring. Interestingly, it was recently demonstrated that ruptured SLB
patches on the surface have accelerating edge fronts, which induce further
rupture of the adsorbed vesicles (Mapar et al., 2018). The rupturing process in
the optical modeling has a characteristic decrease in the linear dispersion
coefficient (dn/dλ) from the initial value of the bulk (­0.02·10­3 nm­1) to the
values corresponding to the fully­formed lipid bilayer (­0.04·10­3 nm­1). Since
the magnitude of the dispersion coefficient was higher for fully­formed
DOPC­SM­Chol SLBs, the decrease in the coefficient may reflect increased
membrane order.
Another way to describe the optical dispersion is the ratio between the
refractive index increments (Eq. 4.5) at two wavelengths, which is useful in
vesicle size and concentration calculations (Rupert et al., 2014, 2016).
Transformation of dn/dλ using refractive index n (670 nm) = 1.48 results in
the ratio of ∼1.02, which has been used as a ratio of refractive index
increments for the 670 nm and 785 nm wavelengths of the MP­SPR
instrument (Rupert et al., 2016). The ratio of SPR responses at the two
wavelengths (R(670nm)/R(785nm)), on the other hand, allows to qualitatively
differentiate between vesicles and bilayer morphologies (∼1.8 for SLBs, <1.7
for SVLs). The refractive index increments are also important in calculating
the surface­mass densities using Eq. 4.5. The results suggest the ranges of
0.15–0.16 mL/g for SLBs and 0.13–0.15 mL/g for SVLs, depending on the
wavelength. Therefore, in principle, the use of a refractive index increment for
SVLs, usually 0.135 mL/g (Chong & Colbow, 1976; Ouberai et al., 2013), can
lead to a roughly 20 % overestimation of the bilayer surface­mass density.
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5.2 IMPLICATIONS FOR SCREENING
DRUG­LIPID INTERACTIONS
5.2.1 INLINE MEASUREMENTS OF MEMBRANE
DISTRIBUTION COEFFICIENTS
Fresnel­layer analysis performed in study II is not particularly useful for
high­throughput applications. In study IV, the essential parameters
describing the binding process were obtained after converting the measured
SPR responses (Ra for analyte or drug, Rl for lipid bilayer) to surface­mass
densities. If the acquired SPR response (Ra) is linearly proportional to the
molar drug concentration in bulk (C), the distribution coefficient can be











where the lipid density (ρl), the molecular weight of the drug (Ma) and
refractive index increment for lipids (dn/dCl,∗ ≈ 0.155 mL/g from II) are
known, and the remaining refractive index increment of the drug is obtainable
from the same SPR measurement inline. The corresponding equation for









Therefore, analysis protocols in IV combined with the above formalisms allow
the measurement of the drug distribution coefficients in a single­experiment
format with a potential analysis required for saturable binding. The advantage
of this approach is also the independence of Eqs. 5.1 and 5.2 from the
sensor­dependent parameters, namely S and δ in Eq. 4.4. Since these
parameters are sensitive to the wearing of the sensor over time, i.e. the
changes in the SiO2 layer thickness (IV, Fig. S1), the analysis presented would
be suitable for sequential screening of drug candidates binding to the
supported lipid bilayer. Current protocols suggest using supported vesicular
systems, which involve multiple labor­intensive steps including
characterization of vesicle coverage and morphology and numerous separate
depositions over a wide range of analyte concentrations (Figueira et al., 2017;
Olaru et al., 2015). Therefore, the presented approach suits for
high­throughput applications, while sacrificing some advantageous properties
of vesicular systems such as increased membrane fluidity when compared to
SLBs.
5.2.2 PARALLELS TO LOG DOCT/W
Octanol­water partition coefficient (log Poct/w) and its pH­dependent
extension, distribution coefficient (log Doct/w), are essential descriptors of
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Table 5.1 Data from the experiments for catechol compounds partitioning to the supported lipid
bilayers. Molar ratios for lipid mixtures were 8:2 (PC­PS), 11:15:6 (PC­PE­PS) and 1:1:1 (PC­SM­
Chol). Binding parameters K and n for L­dopa could not be calculated. The ratios of Michaelis
constants, Km (for substrates), or inhibition constants, Ki (for inhibitors), are calculated from a
kinetic study (Lotta et al., 1995) for both isoforms. In the study of Lotta et al., S­COMT and MB­
COMT were expressed in Escherichia coli and insect Sf9 cells, respectively. Reference values for
the octanol­water partition coefficients are from Forsberg et al. (2005) and Mack & Bönisch (1979).
Other data are adapted from IV, Table 1, with permission from the American Chemical Society (see
details on page ??).
Dopamine L­dopa Entacapone Tolcapone 3­methoxy­
tyramine
Type substrate substrate inhibitor inhibitor metabolite
Structure
Dm
PC 18 1.4 68 572 53
PC­PS 24 0.2 38 325 67
PC­PE­PS 16 0.6 52 343 47
PC­SM­Chol 10 0.5 28 253 13
K(S−COMT)m / i / 13.7 2.3 0.15 0.93 ­
K(MB−COMT)m / i
log Drefoct/w ­2.48a ­2.39a 0.18b 1.03b ­2.22a
H­bonds 7 10 10 8 6
log Dm,pred 1.66 1.02 2.14 2.94 1.94
log Dm
PC 1.26 0.14 1.83 2.76 1.72
PC­PS 1.37 ­0.82 1.58 2.51 1.83
PC­PE­PS 1.21 ­0.20 1.72 2.54 1.67
PC­SM­Chol 1.00 ­0.27 1.45 2.40 1.12
K (M­1)
PC 41 471 2754 304
PC­PS 48 384 1712 704
PC­PE­PS 23 406 2267 110
PC­SM­Chol 25 526 3030 243
n
PC 0.66 0.22 0.31 0.76
PC­PS 0.74 0.15 0.29 0.73
PC­PE­PS 0.96 0.18 0.21 1.21
PC­SM­Chol 0.45 0.06 0.09 0.16
a(Mack & Bönisch, 1979)
b(Forsberg et al., 2005)
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lipophilicity in drug design applications, particularly in quantitative
structure­activity relationship modeling (Mälkiä et al., 2004). Interactions
mainly arising from hydrogen bonding and electrostatic interactions with the
hydrophilic lipid headgroups are, however, not taken into account by these
descriptors. From a purely physicochemical point­of­view, these should be
important for the studied catechol compounds in IV (Table 5.1). The
interaction process can even be biphasic (Raimúndez­Rodríguez et al., 2019),
where the molecule first partitions to the membrane­water interface, and
subsequently, the more lipophilic moieties are driven inside the membrane. A
simple linear model (IV, Eq. S15) was established to predict log Dm from the
physicochemical factors (Table 5.1). Notably, the membrane partitioning
measured for model membranes by (Osanai et al., 2013) and in IV, was
characterized using only two descriptors: log Doct/w and the sum of hydrogen
bond donors and acceptors. Although Osanai et al. used ITC in their binding
studies, other experimental factors were close to those in study IV. The use of
more variables, such as polar surface area, or physiological charge, did not
result in a better model, quantified with the calculated R2­values. The result
agrees with the evaluation of passive BBB permeability, where more than
eight moieties capable of hydrogen­bonding usually does not allow passive
permeation through BBB (Pardridge, 2007). Also, log Doct/w can further reduce
or increase partitioning capacity.
5.3 INTERACTION OF DRUGS & ENDOGENOUS
CATECHOLS WITH THE LIPID MEMBRANE
COULD BE INVOLVED IN THE
CATECHOLAMINE METABOLISM
5.3.1 CATALYTIC MECHANISM OF MB­COMT
In molecular dynamics (MD) simulations, the structure of MB­COMT was
modeled based on the existing S­COMT crystal structure, with the assumption
of an α­helical transmembrane domain together with the putative structure
for the flexible linker segment obtained previously (Orłowski et al., 2011).
Biophysical techniques were used to investigate the differences in membrane
binding of S­ COMT with an identical soluble domain with MB­ COMT, with
(apo) and without (holo) the AdoMet cofactor. Isothermal titration
calorimetry (ITC) experiments revealed that although the change in enthalpy
is practically zero for S­COMT+AdoMet corresponding to the holo form,
notable positive change in entropy can counteract this lack of favorable
interactions. Then, the change in Gibbs free energy is slightly more negative
for S­COMT+AdoMet when compared to COMT or AdoMet alone; however, as
the soluble part of MB­COMT has restricted translational and rotational
freedom due to its lipid­anchored extension, the interactions with the
membrane may differ from the soluble COMT, which can diffuse freely. In MD
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simulations, an initial decrease was seen in the distance between the catalytic
domain and membrane­water interface and subsequent increase in hydrogen
bonds between the domain and lipid headgroups over 100 nanosecond period
(Fig. 5.3A). Thus, initially, the interactions with the membrane may be
limited, but the hydrophobic effect upon the change in the catalytic domain
conformation due to the binding of AdoMet drives the domain and the entire
soluble part closer to the membrane. There, non covalent interactions with the
lipid headgroups may then act as stabilizers of the holo­structure, also
supported by the potential of mean force calculations (III, Fig. 3). QCM and
SPR further showed that holo S­COMT bind irreversibly to the supported lipid
bilayer, while the binding of S­COMT and AdoMet alone was barely in the
limit of the sensitivities of the instruments (Fig. 5.3C).
Figure 5.3 A) Distance between the phosphate headgroup and MB­COMT catalytic site and
the number of hydrogen bonds formed between the catalytic site and membrane headgroups.
Snapshots are shown from the simulation at 0, 100 and 500 ns timepoints. The dashed line marks
the time when holo complex becomes attached to the membrane. B) Thermodynamical parameters
calculated from ITC experiments. Asterisk marks the parameters with high uncertainty. C) Surface­
mass densities calculated using approximative formulas ΓS PR ≈ 600∆θS PR and ΓQCM ≈ 18 (∆ f3/3).
Adapted from III (Figs. 2, S10, & Table S4) with permission from the Royal Society of Chemistry
(see details on page ??).
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The above results provide evidence for a membrane­mediated enzyme
mechanism, where the holo MB­COMT operates at the membrane­water
interface. Therefore, the first requirement for catalysis or inhibition of
MB­ COMT would be binding of the AdoMet cofactor to its binding site, and
then, binding of an interfacial magnesium cation to the catalytic complex.
Finally, the requirement for successful drug targeting of MB­COMT isoform,
or substrate catalysis of endogenous catechols performed by the enzyme, may
be: i) the sufficient partitioning of the drug to the lipid membrane and ii) the
orientation of the hydroxyl moieties in the catechol ring in relation to the
catalytic site (III, Fig. 1). In the next sections, these partitioning effects are
discussed in more detail.
5.3.2 CATECHOL­MEMBRANE INTERACTIONS
Interactions with phosphatidylcholine (PC)
Much of the studies on dopamine­membrane interactions have highlighted
the importance of anionic phospholipids in facilitating dopamine
accumulation to membrane­water interface. On the other hand, zwitterionic
PC has gained less attention due to the limitations of the used instrumentation
(Jodko­Piorecka & Litwinienko, 2013; Orłowski et al., 2012). Studying the
interaction of neurotransmitters with pure PC membranes is beneficial as a
basis, since PC is the most abundant cellular membrane component. In
Table 5.1, the membrane distribution coefficient for dopamine in the PC
membrane is 18, which is the ratio of the local concentration of dopamine in
the membrane and the concentration in bulk (Eqs. 4.10 & 4.8). Surface­mass
density at the highest bulk dopamine concentration, ∼20 ng/cm2, translates
into ∼1.3 nm2 per molecule, meaning that approximately every other PC
molecule is associated with a dopamine molecule at saturation. The same
conclusion arises from the kinetic modeling of the SPR data (IV, Fig. 1), which
gives an estimated number of binding sites, i.e. 0.66 per lipid. Therefore, the
interaction mechanism with PC could be primarily governed by the hydrogen
bonding between the protonated amine and phosphate group of PC balanced
with the electrostatic repulsions between the dopamine molecules and
positive interfacial cations competing with the same binding sites. The
calculated number of hydrogen bonds between the two moieties in previous
MD simulations has been in the range of 0.275–0.805 depending on the
membrane composition (Orłowski et al., 2012).
The notable increase in the distribution coefficient of 3­MT compared to
dopamine (∼3x) and irreversible binding to the SLB suggest that 3­MT can
partition to the membrane interior. Since the binding was irreversible, the
data in Table 5.1 presents the calculations of distribution coefficients using the
linear equation, Eq. 4.10. The methylation effect may be similar to that of
codeine, which has notably higher BBB permeability than morphine, without
the additional methyl group (Hillery et al., 2002, p. 329; Oldendorf et al.,
1972). Hypothetically, the addition of the methyl group could induce an
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orientational shift where the catechol moiety becomes buried in the
hydrophobic interior of the membrane. In contrast, the positively charged
amine group remains at the membrane­ water interface, likely in contact with
the phosphate groups. Since the MAO enzyme metabolizes 3­MT in the outer
leaflet of the mitochondrial membrane, high lipid affinity could be of
importance to the effective disposal of intermediate neurotransmitter
metabolites. For drugs, the opposite could be true. Indeed, high lipophilicity
of tolcapone, with measured log Dm of ∼2.8 in the PC membrane, can be a
contributor to its in vivo liver toxicity (Chen et al., 2013).
L­dopa showed little preference towards the PC membrane, while for other
model membranes, the partitioning was practically nonexistent. The limited
solubility of L­dopa would not allow using higher analyte concentrations. The
zwitterionic nature of the molecule with prominent hydrogen bonding
capacity would explain the tendency of L­dopa to reside in the water phase.
Therefore, physicochemical properties support limited passive permeability
through the BBB, and thus active transport of L­dopa is likely needed (del
Amo et al., 2008). In contrast, these properties seemed to enhance the
membrane binding in the previous studies (Orłowski et al., 2012; Postila et al.,
2016); L­dopa seemed to associate strongly with PC­SM­Chol and PC­PE­PS
membrane models in Langmuir monolayer experiments and MD simulations.
Interactions with phosphatidylserine (PS)
The result that the addition of PS (20 %) to the PC membrane increases the
membrane partitioning by ∼30 % (Table 5.1) is in line with the previous
findings on dopamine­PS interactions (Jodko­Piorecka & Litwinienko, 2013).
Dopamine contains a protonated amine group at physiological pH, which can
interact with the negatively­charged groups of PS, for example, through the
formation of salt bridges. Interactions of PS with dopamine have been
suggested to decrease the availability of neurotransmitters during apoptosis
via accumulation to the membrane­water interface (Jodko­Piorecka &
Litwinienko, 2013). Calcium may prevent this extensive accumulation to the
inner leaflet of the presynaptic vesicle membranes (Mokkila et al., 2017), while
in the postsynaptic cell membrane, PS­induced impairments could originate
from the peroxidation­induced flip­flop of PS to the outer bilayer leaflet
(Fadok et al., 1998; Volinsky et al., 2011). In Parkinson’s disease,
overproduction of the dopamine metabolism­induced lipid peroxidation
products can then lead to disruptions in the membrane composition (Shamim
et al., 2018), and therefore, lipid homeostasis. Also, the PS­modulated effects
on the lateral packing and interfacial hydration (Fig. 5.2C & D) along with
interfacial cation accumulation (Jurkiewicz et al., 2012; Petrache et al., 2004)
highlight that the effects of these disruptions are numerous. Excess of PS may
also induce membrane accumulation of 3­MT, possibly contributing to the
dyskinesias during the L­dopa treatment (Sotnikova et al., 2010). In contrast
to dopamine and 3­MT, distribution coefficients of the MB­COMT inhibitors
tolcapone and entacapone decreased 43 % and 44 %, respectively, attributing
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to their negative net charge in physiological pH. Therefore, PS may also
function as a modulator of drug action.
Interactions with phosphatidylethanolamine (PE)
Although PC­PE­PS membranes showed lower partitioning for dopamine and
3­MT compared to PC­PS membranes at low concentrations, dopamine had
notable binding to the membrane at 80 mM bulk concentration, which was
the highest amount of dopamine used. The sterical unprotection of the PE
amine group could explain the former finding, making it available for charge
repulsion with the neuromodulators having the same positively­charged
amine group. Deficiency in PE, which is prevalent in intracellular membranes
where also MB­COMT should reside, has been linked to alterations in
Parkinsonian α­synuclein homeostasis, leading to, e.g. the inhibition of ER to
Golgi vesicle trafficking (Wang et al., 2014). Since the PE­induced defects in
the SLB morphology cannot be ruled out, it is unclear whether the finding for
the 80 mM bulk concentration is due to the specific interactions with PE or
aggregation of the dopamine inside the supported membrane, however.
Matam et al. (2016) demonstrated that dopamine permeating the lipid bilayer
is indeed possible.
The choice of a ratio (11:15:6) for the PC­PE­PS lipid mixtures in III and
IV was made based on the study of Orłowski et al. (2012), who modeled the
endoplasmic reticulum membrane composition with such ratio. Molecular
dynamics simulations of Orłowski et al. (2012) and Postila et al. (2016) have
shown a notable increase in membrane binding of dopamine and L­dopa for
these PC­PE­PS membranes compared to control membranes with PC only.
This can be due to the overestimation of the binding of cations to PS, as
demonstrated by the recent examination of the MD simulations for lipid
bilayers with PS (Antila et al., 2019). Also, the study concluded that
simulations fail to reproduce the order parameters from NMR experiments.
Therefore, more modest partitioning of the compounds in experiments is
plausible in comparison, and the differences between experiments and
simulations should rise mainly from the interactions of the compounds with
PS. In experiments, further investigations of the SLB morphology would be
needed to optimize the PE  content in the membrane and the SLB formation
conditions for the studies of inner leaflet model membranes (Simonsson &
Höök, 2012).
Interactions with sphingomyelin­cholesterol (SM­Chol)
Partitioning of the catechol molecules in PC­SM­Chol decreased when
compared to other model membranes. Lateral segregation in the used
equimolar composition of PC­SM­Chol might exist as nanodomains
(Koukalová et al., 2017). While it is not possible to deduce if the diminished
binding is due to the lack of specific interactions with domain structures, the
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average percentage ratio of distribution coefficients for all compounds
(PC­SM­Chol / PC), 40 % (Table 5.1), is surprisingly close to the relative
amount of PC in the membrane. On the other hand, binding constants (K), or
affinities, did not differ that much. Thus, it is important to note the difference
between the binding affinity and binding capacity. Affinity is related to the
amount of analyte which is needed to reach the half­maximal binding
capacity. The distribution coefficient is also affected by the binding capacity,
i.e. how many molecules per lipid are bound at full saturation (Eq. 4.8). These
capacities (n in Table 5.1) were 32–79 % lower for the membranes containing
sphingomyelin and cholesterol compared to pure PC membranes. A
straightforward implication would then be that the reduced amount of these
components in the inner leaflet of the postsynaptic cell membrane and
intracellular membranes could contribute to the effective transport of
neurotransmitters and their metabolites inside the postsynaptic neurons.
Although the specifics of the lipid compositions in postsynaptic neuron
compartments are still unknown (Postila et al., 2016), individual membrane
components, such as cholesterol and sphingolipids, are crucial to the
synaptogenesis and synaptic function (Hussain et al., 2019). Understanding
how these components cooperate with neurotransmitters is also vital in
investigating how the synaptic membranes maintain their lateral order and
lipid homeostasis (Tulodziecka et al., 2016) and how aging and
neuropathological conditions are linked to lipid dyshomeostasis (Isacson
et al., 2019). A comprehensive lipidomic analysis of the raft and nonraft
fractions for both healthy brain and brain tissues showing PD­related
pathological lesions did reveal a slight decrease in sphingomyelin and
cholesterol content in the PD raft extracts (Fabelo et al., 2011); however, this
difference was inferred as statistically insignificant. Similar findings exist for
Alzheimer’s disease lipidomics (Kawatsuki et al., 2019). Therefore, cell
biological, lipidomic and biophysical insight to CNS pathologies is needed for
a complete picture of the role of individual lipid components in these diseases,
keeping in mind the uncertainties regarding SM­Chol­dependent
asymmetrical organization in biological membranes (Levental et al., 2020). In
the future, interaction studies with varying cholesterol and sphingomyelin
content, along with incorporated oxidized lipid components, would elucidate
the importance of each factor in the drug and neuromodulatory action.
5.3.3 IMPLICATIONS FOR ENZYME KINETICS
Partitioning of molecules to the membrane
In the traditional Michaelis­Menten kinetics of enzymatic reactions, the
Michaelis constant, Km, and the inhibition constant, Ki, are used in drug
research to characterize the potential efficacy of new drugs before in vivo
pharmacological studies. Higher values of these constants mean that the
higher concentrations of the substrate or inhibitor are needed to reach the
maximum catalytic rate of the system or inhibit the reaction maximally,
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respectively. Therefore, it is plausible that the ratio of these constants in the
absence of the membrane (S­COMT) and with the membrane (MB­COMT)
could correspond to the ratio of analyte concentrations between the
membrane and bulk, i.e. the distribution coefficient Dm. Similarly, lower
maximal catalytic rate (Vmax) for MB­COMT could be explained by the
increased turnover time for the ligands resulting from the membrane
interactions. This theory is also supported by the findings from the early
studies that membrane solubilization using Triton­X effectively abolishes the
differences in catalytic properties between the two isoforms (Jeffery & Roth,
1984). An alternative explanation is that substrates can bind to the extra
N­terminal amino acids present in MB­COMT (Bai et al., 2007).
Based on the results in Table 5.1, the quantitative correlation between the
ratio K(S−COMT)m / i /K
(MB−COMT)
m / i and Dm is present for the substrates (dopamine,
L­dopa), but not for the inhibitors (tolcapone, entacapone). Higher membrane
affinity of tolcapone compared to entacapone is, however, qualitatively in line
with that tolcapone is more specific to MB­COMT, also argued based on the
potential of mean force calculations (III, Fig. S5). Tolcapone and entacapone
are tight­binding inhibitors, with Ki’s in the range of nanomoles per liter
(Lotta et al., 1995; Nissinen et al., 1992). While inhibitory constants are more
reliable than the commonly­used IC50­values, which describe the relative
inhibitory potency of compounds at specific experimental conditions,
tight­binding nature of an inhibitor makes it challenging to make conclusions
regarding the mode of inhibition (competitive or noncompetitive) and relative
selectivity between the two isoforms (Borges et al., 1997). Also, if MB­COMT
indeed functions as an interfacial enzyme, Michaelis­Menten kinetics could be
only seen as a simplification of the underlying kinetics which has complex
dependencies on the individual kinetic parameters of the enzyme­ligand and
ligand­membrane interactions. Furthermore, molecular crowding in cells
potentially makes the diffusion as a rate­limiting step in enzymatic reactions
in vivo (Zotter et al., 2017).
Orientation of molecules in the membrane
In addition to partitioning between the membrane and water phases,
catecholamine and drug action could be sensitive to the orientations of the
molecules at the lipid ­water interface. MD simulations performed for some of
the inhibitors studied by Robinson et al. (2012) showed that inhibitors
selective for MB­COMT (lower IC50) would orient in the way that the hydroxyl
groups susceptible to catalysis are closer to the membrane normal (III, Fig. 1).
Tolcapone, which can also be methylated, mostly in the 3O­position (Jorga
et al., 1999), has its 3O­hydroxyl close to parallel to the membrane normal on
average (Fig. 5.4). The methylbenzene moiety in the opposing end,
corresponding to nonpolar solvent toluene, is hydrophobic. A similar
orientation has been previously experimentally proposed for dopamine
(Matam et al., 2016), shown in Fig. 5.4. On the other hand, entacapone is
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Figure 5.4 Artistic representation of the possible orientations for entacapone, tolcapone (from
MD simulations in II, Fig. 1A) and dopamine (Matam et al., 2016) at the membrane­water interface.
more likely to orient parallel to the membrane surface, which would make the
reactive groups less available for binding with the enzyme.
With these findings in mind, it is of interest to consider the
physicochemical features of few potent MB­COMT inhibitors developed
during recent years. First, some of the nitrocatechol­based compounds
studied by Silva et al. (2016) showed high BBB permeability, lipophilicity and
preference towards the rat brain COMT, comparable to tolcapone.
Interestingly, molecules that were generally more specific towards total brain
COMT contain chemical groups that make parts of the molecule excluding the
nitrocatechol ring more lipophilic, and to some extent, have reduced polar
surface area. Four most selective molecules had the ratio of IC50 values
between 17.2 and 27.3, while the ratio of c log P’s between the part excluding
the catechol moiety and the entire molecule, is 0.69 to 0.75. For the two least
specific molecules with IC50 ratios of 0.55 and 1.83, the corresponding ratios
are ­0.28 and ­0.19, respectively. It is then plausible that lipophilicity of the
molecule at the opposing end of the nitrocatechol ring would make the
molecule orient at the membrane­water interface in the same manner as
tolcapone. While log Poct/w may not be an accurate predictor of membrane
partitioning for charged and polar compounds, as discussed, it can be useful
in the presented exploratory comparisons.
Pinheiro et al. (2019) showed later that one of the compounds of their
previous study, CNCAPE, inhibited brain MB­COMT (IC50 of 2.4 nM) as much
as tolcapone, while inhibitory potency in the liver was much lower (27.0 nM
for liver MB­COMT and 213.0 nM for liver S­COMT). 8­hydroxyquinolines
studied by Buchler et al. (2018) showed notable potency towards human
MB­COMT, but the parallels with the theories presented are less clear due to
the presence of the quinoline moiety instead of a catechol ring. Nevertheless,
nonpolar extensions introduced to the quinoline moiety via a sulfonyl group
seem to enhance MB­COMT selectivity, while the polar trifluoromethyl group
(­CF3) at the end of a benzene extension diminished it. Optimization of the
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physicochemical properties of both the reactive part of a drug and the
opposite lipophilic moieties, therefore, offer exciting possibilities for the
design of novel MB­COMT selective compounds using in silico approaches,
much needed for constantly­more expensive drug development pipelines.
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6 FUTURE PROSPECTS
This thesis has highlighted the importance of the lipid membrane in integral
membrane protein functionality. Despite the outstanding advances in the field
of structural biophysics, membrane protein structures remain vastly
underrepresented in the structural databases. Cryo­EM and NMR techniques,
in particular, have evolved to the point where it is feasible to study integral
membrane proteins, relevant drug targets, in their natural lipid environment
(Baker et al., 2018; Shiraishi et al., 2018; Yin & Flynn, 2016). Based on the
view of the critical role of lipids in the protein functionality, structures derived
using detergent­based solubilization methods should be revisited (Chipot
et al., 2018) and new detergent­free platforms developed (Lee et al., 2016;
Lundgren et al., 2018; Parmar et al., 2018; Simeonov et al., 2013). Also,
chemical synthesis and modification methods for the de novo production of
structurally sensitive membrane proteins have exciting possibilities for
proteins that are difficult to purify (Agouridas et al., 2019; Baumruck et al.,
2018). Approaches in lipidomics (Bolla et al., 2019; Shamim et al., 2018) and
microarray technologies (Saliba et al., 2015) used in tandem with the
information gained from structural biology may aid in establishing
connections between lipid homeostasis and lipid­assisted dynamical folding of
membrane proteins (Dowhan et al., 2019).
Progress in the biophotonic methodologies is essential to the studies of
biological processes. Improvement in the spatiotemporal resolution from the
current instruments is required to resolve the nanoscale dynamical events in
model systems and living organisms. Recently, combinations of different
microscopy techniques have demonstrated the importance of the actin
cytoskeleton in regulating plasma membrane diffusion (Schneider et al.,
2017), and three­dimensional diffusion has been measured in living cells
using STED­FCS (Lanzanò et al., 2017). Guo et al. (2018) improved the lateral
resolution of TIRF microscopy to 115 nm using instant structured illumination
microscopy. Novel holography techniques can provide insight into how cells
react to environmental changes due to drugs, for example (Midtvedt et al.,
2019). Multi­wavelength (Lakayan et al., 2019) and label­enhanced (Eng
et al., 2018, 2016) extensions of the SPR instrumentation increase the
capabilities of analysis and sensitivity, respectively. The uncertainties due to
the existence of multiple unknown system parameters are also reduced.
Localized SPR (Lee et al., 2018; Olaru et al., 2015) and time­resolved
surface­enhanced Raman scattering spectroscopy (Kögler et al., 2020) are
examples of label­free biophotonic techniques which have improved sensing
capabilities compared to their predecessors (Wang et al., 2017). Molecular
dynamics simulations and computational analysis workflows are useful tools
to complement experiments in the investigations of drug action (Fantin et al.,
2019; Riedlová et al., 2017; Rodríguez­Espigares et al., 2018) and cellular
functions (Bocharov et al., 2019; Enkavi et al., 2019; Postila et al., 2016). In
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this regime, the efforts to improve the correlation between the simulations
and experiments (Antila et al., 2019; Javanainen et al., 2018) are continuing.
All methodologies above accompany each other in the investigations of the
interactions between lipid environment, membrane proteins and drug
compounds related to biological function and states of disease.
Kinetics of the chemical reactions at the lipid­water interface (Bondar &
Keller, 2018; Bondar & Lemieux, 2019) and the mechanisms driving
heterogeneity of the membranes still need further clarification, especially
concerning membrane curvature and lipid asymmetry (Cebecauer et al., 2018;
Sezgin et al., 2017). Drug delivery strategies for currently untreatable diseases
both in CNS and periphery benefit from comprehensive characterization
studies on extracellular vesicles (Maeki et al., 2018; Rupert et al., 2018, 2016;
Saari et al., 2015), also concerning the role of lipids in their functionality
(Holopainen et al., 2019). The presence of membrane­bound
catechol­O­methyltransferase (MB­COMT) activity in EVs and microsomes
from rat hepatocytes (Casal et al., 2016) and the role of EVs in
neurodegenerative diseases (Quek & Hill, 2017) have particularly interesting
parallels to the topics of this thesis. The formation of protein corona
structures on the surfaces of natural and endogenous vesicle carriers in bodily
fluids have important implications for both drug delivery applications
(Giulimondi et al., 2019; Zhang et al., 2019) and understanding processes
involved in complex diseases such as cancer (Caracciolo et al., 2019) and
Alzheimer’s disease (Nandakumar et al., 2020). For example, the viral protein
corona of herpes simplex virus type 1 can modulate the amyloid β­ peptide
aggregation relevant in amyloid plaque pathologies (Ezzat et al., 2019).
Apo­ and holo­structures of the entire MB­COMT protein in the presence
of the lipid membrane should provide more insight into its catalytic
mechanism; however, previous efforts to purify MB­COMT in its catalytically
active form (Pedro et al., 2018, 2015) suggest the protein is inherently
unstable outside its natural environment. Meanwhile, biophysical tools
combined with protein expression and peptide chemistry techniques can
elucidate the functionality of individual protein segments of MB­ COMT, such
as the linker region with a putative location in the membrane­water interface.
These studies can explicate the function of catalytic membrane proteins with
similar topological properties, abundant in the human proteome. Finally, the
development of novel COMT inhibitors for CNS targeting continues, with an
increasing focus on the BBB permeability and selectivity for the




Various biophysical techniques were utilized in this thesis for studying model
lipid membranes. For the first time, fluorescence correlation spectroscopy
was combined with a Langmuir monolayer trough to investigate the
dynamics of domain­forming model membranes (I). The main challenge was
that multiple fluorescence intensity time traces had to be recorded by
scanning along the optical axis. After the autocorrelation analysis of the time
traces, the minimum diffusion times corresponding to the positions of the
monolayer could be extracted, and these diffusion times were then related to
the surface pressures measured simultaneously. As a principal method in the
thesis, multi­parametric surface plasmon resonance in a dual­wavelength
format was employed, allowing nanoscale characterization of supported lipid
bilayers and quantitative analysis of analyte­lipid interactions. While
Fresnel­layer analysis in a proprietary software was used in the
characterization of the SLBs (II), the Jung model was later adopted in a
home­made Python workflow for the bulk effect correction and data analysis
(IV). As a complementary technique, impedance­based quartz crystal
microbalance provided information regarding the sensor­coupled water to
find the exact solutions for the biophysical properties of the SLBs (II). In the
studies of the binding of catechol analytes to the SLBs (IV), significant
differences in the surface­mass densities calculated for SPR and QCM
techniques suggest that the frequency and energy dissipation shifts in QCM
can be strongly influenced by factors not related to the actual analyte binding.
After the analyte binding, the viscoelastic modeling of the SLBs resulted in
vast mass variations between membrane formulations, even after taking into
account the changes in bulk properties due to the high concentrations of
analytes. Finally, isothermal titration calorimetry was used to study the
thermodynamics of the S­COMT–vesicle interactions (III). The
non­sigmoidal decrease in the heights of the enthalpy peaks upon the titration
of vesicles may have resulted in a high error of the modeled thermodynamical
parameters, probably because concentrations of the interaction constituents
were not optimized in the binding assay. The results are qualitatively in line
with the SPR and QCM measurements, however, which showed irreversible
membrane binding of S­COMT together with the AdoMet cofactor.
Drug action can be understood as a delicate interplay between the essential
molecular constituents composing the local environment of the drug target.
These targets may be membrane proteins which function directly at the
lipid­water interface, demonstrated in this thesis by the proposed action of
membrane­bound catechol­O­methyltransferase, an essential target for many
anti­Parkinson agents (III). Sufficient local concentration and proper
orientation of a drug in the interface could be a requirement for the
drug­target binding (III, IV). Consequently, since the changes in the
membrane composition and morphology may modulate drug action (IV), the
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characterization of lipid membranes and the development of tools for their
analysis is critical (I, II). Peroxidation­induced acyl chain truncation of the
lipid tails may influence the dynamics of domain structures enriched with
sphingomyelin and cholesterol (I). These results suggest that these
modifications might compromise the intrinsic physical properties maintained
in the membranes, despite that the correspondence of these structures to the
heterogeneities in biological membranes is still under debate.
Phosphatidylserine can modulate the drug action via electrostatic
interactions, and the inclusion of sphingomyelin and cholesterol in model
membranes with phosphatidylcholine effectively diminishes the interaction of
catechol compounds with the membrane (IV). Therefore, deviations from the
natural prevalence and distribution of the membrane constituents might be
detrimental for neuronal function. In conclusion, the results of this thesis
highlight the relationships between lipid membranes and the action of drugs
and other small molecular compounds with membrane protein targets. The
thesis also describes the analysis and modeling protocols for surface­sensitive
analytical technologies, which can aid future drug screening efforts and
studies of biological interactions using model lipid membranes.
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